<html><body><document>
<type>424B3
<sequence>1
<filename>tm2122043d1_424b3.htm
<description>424B3
<text>
<title></title>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>Filed Pursuant to Rule 424(b)(3)</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>Registration No. 333-257565</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b>&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROSPECTUS</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img alt="" src="https://www.sec.gov/Archives/edgar/data/0001718405/000110465921091694/tm2122043d1_424b3sp1img01.jpg"/>&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>HYCROFT MINING HOLDING CORPORATION</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>69,814,676 shares of Common Stock</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>19,161,491 Warrants</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>47,442,361 shares of Common Stock Issuable upon
Exercise of Warrants</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">This prospectus relates to: (1) the issuance by
us of up to (i) 34,289,898 shares of Class A common stock, par value $0.0001 per share (&#8220;Common Stock&#8221;), of Hycroft Mining
Holding Corporation, a Delaware corporation that may be issued upon exercise of warrants, including the public warrants, private placement
warrants, forward purchase warrants and PIPE warrants (as such terms are defined under &#8220;Selected Definitions&#8221;) at an exercise
price of $11.50 per share of Common Stock, (ii) 9,583,334 October 2020 warrants (as such terms are defined under &#8220;Selected Definitions&#8221;)
at an exercise price of $10.50 per share of Common Stock, and (iii) 3,569,129 shares of Common Stock that may be issued upon exercise
of the Seller warrants (as such term is defined under &#8220;Selected Definitions&#8221;) at an exercise price, determined as of January
19, 2021 pursuant to the Seller Warrant Agreement (as such term is defined under &#8220;Selected Definitions&#8221;), of $40.31 per share
upon the exercise of 12,721,901 Seller warrants, each currently exercisable into approximately 0.28055 shares of Common Stock, which exercise
price and number of shares may fluctuate under the terms of the Seller Warrant Agreement; and (2) the offer and sale, from time to time,
by the selling security holders identified in this prospectus (the &#8220;Selling Securityholders&#8221;), or their permitted transferees
of up to (i) 69,814,676 shares of Common Stock, and (ii) up to 19,161,491 warrants to purchase shares of Common Stock, including the private
placement warrants, forward purchase warrants, PIPE warrants and October 2020 warrants and subsequently acquired public warrants.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">This prospectus provides you with a general description
of such securities and the general manner in which we and the Selling Securityholders may offer or sell the securities. More specific
terms of any securities that we and the Selling Securityholders may offer or sell may be provided in a prospectus supplement that describes,
among other things, the specific amounts and prices of the securities being offered and the terms of the offering. The prospectus supplement
may also add, update or change information contained in this prospectus.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We will not receive any proceeds from the sale
of the securities under this prospectus, although we could receive up to approximately $582 million for the issuance by us of the Common
Stock registered under this prospectus assuming the exercise of all of the registered and outstanding public warrants, private placement
warrants, forward purchase warrants, PIPE warrants, October 2020 warrants and Seller warrants, to the extent such warrants are exercised
for cash. However, we will pay the expenses associated with the sale of securities pursuant to this prospectus. Any amounts we receive
from such exercises will be used for working capital and other general corporate purposes.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Information regarding the Selling Securityholders,
the amounts of shares of Common Stock and warrants that may be sold by them and the times and manner in which they may offer and sell
the shares of Common Stock and warrants under this prospectus is provided under the sections entitled &#8220;<i>Selling Securityholders</i>&#8221;
and &#8220;<i>Plan of Distribution,</i>&#8221; respectively, in this prospectus. We have not been informed by any of the Selling Securityholders
that they intend to sell their securities covered by this prospectus and do not know when or in what amount the Selling Securityholders
may offer the securities for sale. The Selling Securityholders may sell any, all, or none of the securities offered by this prospectus.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p>
<!-- Field: Page; Sequence: 1 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"> </p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Selling Securityholders and intermediaries
through whom such securities are sold may be deemed &#8220;underwriters&#8221; within the meaning of the Securities Act of 1933, as amended,
with respect to the securities offered hereby, and any profits realized or commissions received may be deemed underwriting compensation.
We have agreed to indemnify certain of the Selling Securityholders against certain liabilities, including liabilities under the Securities
Act.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">You should read this prospectus and any prospectus
supplement or amendment carefully before you invest in our securities.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our Common Stock, our public warrants, or October
2020 warrants and our Seller warrants are listed on The Nasdaq Capital Market, under the symbols &#8220;HYMC,&#8221; &#8220;HYMCW,&#8221;
 &#8220;HYMCL,&#8221; and &#8220;HYMCZ,&#8221; respectively. On July 12, 2021, the last reported sales price of our Common Stock listed
under the symbol HYMC was $2.74 per share, the last reported sales price of our public warrants listed under the symbol HYMCW was $0.39
per warrant, the last reported sales price of our October 2020 warrants listed under the symbol HYMCL was $0.79 per warrant, and the last
reported sales price of our Seller warrants listed under the symbol HYMCZ was $0.48 per warrant.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b>We are an &#8220;emerging growth company&#8221;
under federal securities laws and are subject to reduced public company reporting requirements. Investing in our common stock involves
a high degree of risk. See &#8220;<i>Risk&#160;Factors</i></b>&#8221; beginning on page&#160;6 of this prospectus.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of these securities, or determined if this prospectus is truthful or complete.
Any representation to the contrary is a criminal offense.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">You should rely only on the information contained
in this prospectus. We have not authorized any dealer, salesperson or other person to provide you with information about the Company,
except for the information contained in this prospectus. The information contained in this prospectus is complete and accurate only as
of the date on the front cover page&#160;of this prospectus, regardless of the time of delivery of this prospectus or the sale of any
securities. This prospectus is not an offer to sell these securities and we are not soliciting an offer to buy these securities in any
state where the offer or sale is not permitted. The information contained in this prospectus may change after the date of this prospectus.
Do not assume after the date of this prospectus that the information contained in this prospectus is still correct.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">For investors outside the United States: We have
not done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for
that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus
must inform themselves about, and observe any restrictions relating to, the offering and the distribution of this prospectus outside the
United States.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>The date of this prospectus is July 13, 2021</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">TABLE OF CONTENTS</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 90%; padding-bottom: 6pt; padding-left: 0.5in; text-indent: -0.5in"><a href="#am_001"><font style="font-size: 10pt">ABOUT THIS PROSPECTUS</font></a></td>
<td style="width: 10%; padding-bottom: 6pt; text-align: right"><a href="#am_001"><font style="font-size: 10pt">iv</font></a></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-bottom: 6pt; padding-left: 0.5in; text-indent: -0.5in"><a href="#am_002"><font style="font-size: 10pt">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</font></a></td>
<td style="padding-bottom: 6pt; text-align: right"><a href="#am_002"><font style="font-size: 10pt">iv</font></a></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding-bottom: 6pt; padding-left: 0.5in; text-indent: -0.5in"><a href="#am_003"><font style="font-size: 10pt">SELECTED DEFINITIONS</font></a></td>
<td style="padding-bottom: 6pt; text-align: right"><a href="#am_003"><font style="font-size: 10pt">vii</font></a></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-bottom: 6pt; padding-left: 0.5in; text-indent: -0.5in"><a href="#am_004"><font style="font-size: 10pt; text-transform: uppercase">PROSPECTUS SUMMARY</font></a></td>
<td style="padding-bottom: 6pt; text-align: right"><a href="#am_004"><font style="font-size: 10pt; text-transform: uppercase">1</font></a></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding-bottom: 6pt; padding-left: 0.5in; text-indent: -0.5in"><a href="#a_001"><font style="font-size: 10pt; text-transform: uppercase">RISK FACTORS</font></a></td>
<td style="padding-bottom: 6pt; text-align: right"><a href="#a_001"><font style="font-size: 10pt; text-transform: uppercase">6</font></a></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-bottom: 6pt; padding-left: 0.5in; text-indent: -0.5in"><a href="#a_002"><font style="font-size: 10pt; text-transform: uppercase">USE OF PROCEEDS</font></a></td>
<td style="padding-bottom: 6pt; text-align: right"><a href="#a_002"><font style="font-size: 10pt; text-transform: uppercase">6</font></a></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding-bottom: 6pt; padding-left: 0.5in; text-indent: -0.5in"><a href="#a_003"><font style="font-size: 10pt; text-transform: uppercase">WHERE YOU CAN FIND MORE INFORMATION</font></a></td>
<td style="padding-bottom: 6pt; text-align: right"><a href="#a_003"><font style="font-size: 10pt; text-transform: uppercase">6</font></a></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-bottom: 6pt; padding-left: 0.5in; text-indent: -0.5in"><a href="#a_004"><font style="font-size: 10pt; text-transform: uppercase">SELLING SECURITYHOLDERS</font></a></td>
<td style="padding-bottom: 6pt; text-align: right"><a href="#a_004"><font style="font-size: 10pt; text-transform: uppercase"><b>7</b></font></a></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding-bottom: 6pt; padding-left: 0.5in; text-indent: -0.5in"><a href="#a_005"><font style="font-size: 10pt; text-transform: uppercase">PLAN OF DISTRIBUTION</font></a></td>
<td style="padding-bottom: 6pt; text-align: right"><a href="#a_005"><font style="font-size: 10pt; text-transform: uppercase">12</font></a></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-bottom: 6pt; padding-left: 0.5in; text-indent: -0.5in"><a href="#a_006"><font style="font-size: 10pt; text-transform: uppercase">DESCRIPTION OF SECURITIES TO BE REGISTERED</font></a></td>
<td style="padding-bottom: 6pt; text-align: right"><a href="#a_006"><font style="font-size: 10pt; text-transform: uppercase">14</font></a></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding-bottom: 6pt; padding-left: 0.5in; text-indent: -0.5in"><a href="#a_007"><font style="font-size: 10pt; text-transform: uppercase">INTEREST OF NAMED EXPERTS AND COUNSEL</font></a></td>
<td style="padding-bottom: 6pt; text-align: right"><a href="#a_007"><font style="font-size: 10pt; text-transform: uppercase">24</font></a></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-bottom: 6pt; padding-left: 0.5in; text-indent: -0.5in"><a href="#a_008"><font style="font-size: 10pt; text-transform: uppercase">INCORPORATION BY REFERENCE</font></a></td>
<td style="padding-bottom: 6pt; text-align: right"><a href="#a_008"><font style="font-size: 10pt; text-transform: uppercase">24</font></a></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding-bottom: 6pt; padding-left: 0.5in; text-indent: -0.5in"><a href="#a_009"><font style="font-size: 10pt; text-transform: uppercase">LEGAL MATTERS</font></a></td>
<td style="padding-bottom: 6pt; text-align: right"><a href="#a_009"><font style="font-size: 10pt; text-transform: uppercase">25</font></a></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<!-- Field: Page; Sequence: 3; Value: 2 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><a name="am_001"></a>ABOUT THIS PROSPECTUS</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase"><b>&#160;</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>As used in this prospectus, unless the context
otherwise requires or indicates, references to &#8220;Hycroft,&#8221; &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us,&#8221;
refer to Hycroft Mining Holding Corporation and its subsidiaries. &#8220;Seller&#8221; refers to Hycroft Mining Corporation prior to the
Recapitalization Transaction.</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The information contained in this prospectus is
not complete and may be changed. You should rely only on the information provided in or incorporated by reference in this prospectus,
in any prospectus supplement or in a related free writing prospectus, or documents to which we otherwise refer you. We have not authorized
anyone else to provide you with different information.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b>We have not authorized any dealer, agent or
other person to give any information or to make any representation other than those contained or incorporated by reference in this prospectus
and any accompanying prospectus supplement. You must not rely upon any information or representation not contained or incorporated by
reference in this prospectus or an accompanying prospectus supplement or any related free writing prospectus. This prospectus and any
accompanying prospectus supplement, if any, do not constitute an offer to sell or the solicitation of an offer to buy any securities other
than the registered securities to which they relate, nor do this prospectus and any accompanying prospectus supplement, if any, constitute
an offer to sell or the solicitation of an offer to buy securities in any jurisdiction to any person to whom it is unlawful to make such
offer or solicitation in such jurisdiction. You should not assume that the information contained in this prospectus and any accompanying
prospectus supplement, if any, is accurate on any date subsequent to the date set forth on the front of such document or that any information
we have incorporated by reference is correct on any date subsequent to the date of the document incorporated by reference, even though
this prospectus and any accompanying prospectus supplement, if any, is delivered or securities are sold on a later date.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We further note that the representations, warranties
and covenants made by us in any agreement that is filed as an exhibit to any document that is incorporated by reference in this prospectus
were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among
the parties to such agreements, and should not be deemed to be a representation, warranty or covenant to you. Moreover, such representations,
warranties or covenants were accurate only as of the date when made. Accordingly, such representations, warranties and covenants should
not be relied on as accurately representing the current state of our affairs.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">You should assume that the
information in this prospectus is accurate only as of the date of this prospectus.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><a name="am_002"></a>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase"><b>&#160;</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Certain statements in this prospectus, including
documents incorporated by reference herein, may constitute &#8220;forward-looking&#8221; statements as defined in Section 27A of the Securities
Act of 1933, as amended (the &#8220;Securities Act&#8221;), Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange
Act&#8221;), the Private Securities Litigation Reform Act of 1995 (the &#8220;PSLRA&#8221;) or in releases made by the SEC, all as may
be amended from time to time. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors
that could cause actual results, performance or achievements of Hycroft or industry results, to differ materially from any future results,
performance or achievements expressed or implied by such forward-looking statements. Statements that are not historical fact are forward-looking
statements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"></p>
<!-- Field: Page; Sequence: 4; Value: 2 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Forward-looking statements can be identified
by, among other things, the use of forward-looking language, such as the words &#8220;plan,&#8221; &#8220;believe,&#8221;
 &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;estimate,&#8221; &#8220;believe,&#8221;
 &#8220;target,&#8221; &#8220;budget,&#8221; &#8220;project,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;would,&#8221;
 &#8220;could,&#8221; &#8220;should,&#8221; &#8220;seeks,&#8221; or &#8220;scheduled to,&#8221; or other similar words, or the
negative of these terms or other variations of these terms or comparable language, or by discussion of strategy or intentions. These
cautionary statements are being made pursuant to the Securities Act, the Exchange Act and the PSLRA with the intention of obtaining
the benefits of the &#8220;safe harbor&#8221; provisions of such laws. We caution investors that any forward-looking statements made
by us are not guarantees or indicative of future performance. Important assumptions and other important factors that could cause
actual results to differ materially from those forward-looking statements with respect to us include, but are not limited to, the
risks and uncertainties affecting our businesses described in the &#8220;Risk factors&#8221; section in this prospectus and
described in &#8220;<i>Item 1A. Risk Factors</i>&#8221; of Hycroft&#8217;s Amended <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1718405/000171840521000029/hymc-20201231.htm" style="-sec-extract: exhibit">Annual Report on Form 10-K/A for the year ended December 31, 2020</a> and in other filings by Hycroft with the SEC incorporated by reference herein. Important factors, risks and
uncertainties that could cause actual results to differ materially from those forward-looking statements include, but are not
limited to:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td><font style="font-size: 10pt">Use of proceeds from this offering;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td><font style="font-size: 10pt">Industry-related risks including:</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td><font style="font-size: 10pt">Fluctuations in the price of gold and silver;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td><font style="font-size: 10pt">Uncertainties concerning estimates of mineral reserves and mineral resources;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td><font style="font-size: 10pt">Uncertainties relating to the COVID-19 pandemic;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td><font style="font-size: 10pt">The intense competition within the mining industry;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td><font style="font-size: 10pt">The inherently hazardous nature of mining activities, including environmental risks;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td><font style="font-size: 10pt">Our insurance may not be adequate to cover all risks associated with our business, or cover the replacement costs of our assets or may not be available for some risks;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td><font style="font-size: 10pt">Potential effects on our operations of U.S. federal and state governmental regulations, including environmental regulation and permitting requirements;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td><font style="font-size: 10pt">Cost of compliance with current and future government regulations;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Uncertainties relating to obtaining or retaining approvals and permits from governmental regulatory authorities;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Potential challenges to title in our mineral properties;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Risks associated with legislation in Nevada that could significantly increase the costs or taxation of our operations; and</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Changes to the climate and regulations and pending legislation regarding climate change.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Business-related risks including:</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Risks related to our liquidity and going concern considerations;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Risks related to our ability to raise capital on favorable terms or at all;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Risks related to the proprietary two-stage heap oxidation and leach process at the Hycroft Mine and estimates of production;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Our ability to achieve our estimated production and sales rates and stay within our estimated operating and production costs and capital expenditure projections;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Risks related to a decline in our gold and silver production;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Our ability to successfully eliminate or meaningfully reduce processing and mining constraints; the results of our planned 2021 technical efforts and how the data resulting from such efforts could adversely impact processing technologies applied to our ore, future operations and profitability;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<!-- Field: Page; Sequence: 5; Value: 2 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence --></p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Risks related to our reliance on one mine with a new process;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Risks related to our limited experience with a largely untested process of oxidizing and heap leaching sulfide ore;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Uncertainties and risks related to our reliance on contractors and consultants;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Availability and cost of equipment, supplies, energy, or commodities;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">The commercial success of, and risks relating to, our development activities;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Risks related to slope stability;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Risks related to our substantial indebtedness, including cross acceleration and our ability to generate sufficient cash to service our indebtedness;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Uncertainties resulting from the possible incurrence of operating and net losses in the future;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Uncertainties related to our ability to replace and expand our mineral reserves;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">The costs related to our land reclamation requirements;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">The loss of key personnel or our failure to attract and retain personnel;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Risks related to technology systems and security breaches;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Any failure to remediate and possible litigation as a result of a material weakness in our internal controls over financial reporting; and</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Risks that our principal stockholders will be able to exert significant influence over matters submitted to stockholders for approval.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt; text-align: justify"><font style="font-size: 10pt">Risks related to our Common Stock and warrants, including</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Volatility in the price of our Common Stock and warrants;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Potential declines in the value of our Common Stock and warrants due to substantial future sales of our Common Stock and/or warrants;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Risks that warrants may expire worthless;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">The valuation of our 5-Year Private Warrants (as such term is defined under &#8220;Selected Definitions&#8221;) could increase the volatility of our net income (loss);</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Anti&#8211;takeover provisions could make a third-party acquisition of us difficult; and</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Risks related to limited access to our financial information, as we have elected to take advantage of the disclosure requirement exemptions granted to emerging growth companies and smaller reporting companies.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">These statements involve known and unknown risks,
uncertainties, assumptions and other factors which may cause our actual results, performance or achievements to be materially different
from any results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are
based on current expectations. Although our management believes that its expectations are based on reasonable assumptions, we can give
no assurance that these expectations will prove correct. Please see &#8220;<i>Risk Factors</i>&#8221; for more information about these
and other risks. Potential investors are cautioned against attributing undue certainty to forward-looking statements. Although we have
attempted to identify important factors that could cause actual results to differ materially from those described in forward-looking statements,
there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that our forward-looking
statements will prove to be accurate as actual results and future events could differ materially from those anticipated in the statements.
The forward-looking statements contained in this prospectus, any prospectus supplement, or the documents incorporated herein by reference
are made only as of the date hereof and we do not have or undertake any obligation to update or revise any forward-looking statements
whether as a result of new information, subsequent events or otherwise, unless otherwise required by law.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p>
<!-- Field: Page; Sequence: 6; Value: 2 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vi<!-- Field: /Sequence --></p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase"><b><a name="am_003"></a>SELECTED
DEFINITIONS</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase"><b>&#160;</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Unless stated in this prospectus or the context
otherwise requires, references to:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>&#8220;</i>2020 Financial Statements<i>&#8221;
</i>means our consolidated financial statements for the year ended December&#160;31, 2020 and the notes thereto.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>&#8220;</i>2020 Notes<i>&#8221; </i>means the
notes to the 2020 Financial Statements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;5-Year Private Warrants&#8221; means the
private placement warrants and the forward purchase warrants less any such warrants transferred from an initial purchaser of such warrants
to someone other than the initial purchasers of the 5-Year Private Warrants or their permitted transferees.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;Amended and Restated Registration Rights
Agreement&#8221; means that certain Amended and Restated Registration Rights Agreement entered into at the closing of the Recapitalization
Transaction, by and among the Company and the restricted stockholders.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;Amended Annual Report&#8221; means Hycroft
Mining Holding Corporation&#8217;s amended Annual Report on Form 10-K/A for the year ended December 31, 2020, filed on May 14, 2021</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;Acquisition Sub&#8221; means MUDS Acquisition
Sub,&#160;Inc., a Delaware corporation and an indirect, wholly-owned subsidiary of the Company.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;Aristeia&#8221; means Aristeia Capital,
LLC.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;Board&#8221; means the board of directors
of Hycroft Mining Holding Corporation.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;business day&#8221; means a day, other
than Saturday, Sunday or such other day on which commercial banks in New York, New York are authorized or required by applicable laws
to close.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;Cantor&#8221; means Cantor Fitzgerald&#160;&amp;
Co.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;Common Stock&#8221; means the Class&#160;A
common stock, par value $0.0001 per share, of the Company.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;DGCL&#8221; means the General Corporation
Law of the State of Delaware.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;effective time&#8221; means 9:00 a.m.&#160;New
York time on May&#160;29, 2020.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;Exchange Act&#8221; means the Securities
Exchange Act of 1934, as amended and the rules&#160;and regulations promulgated thereunder.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;Feasibility Study&#8221; means the NI 43-101
Technical Report: Heap Leaching Feasibility Study prepared by M3 Engineering and Technology Corporation with an effective date of July&#160;31,
2019, which formed the substantive basis for the Hycroft Technical Report that was prepared to comply with subpart 1300 of Regulation
S-K.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p>
<!-- Field: Page; Sequence: 7; Value: 2 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vii<!-- Field: /Sequence --></p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;Forward Purchase Contract&#8221; means
the Forward Purchase Contract, dated January&#160;24, 2018, by and between the Company and sponsor, pursuant to which sponsor purchased
3,125,000&#160;shares of Common Stock and 2,500,000 forward purchase warrants exercisable at $11.50 per share, for gross proceeds of $25,000,000,
concurrently with the consummation of the Recapitalization Transaction.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;forward purchase warrants&#8221; means
the warrants to purchase one share of Common Stock at a price of $11.50 per share issued to the sponsor upon consummation of the Recapitalization
Transaction pursuant to the Forward Purchase Contract.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;Highbridge&#8221; means Highbridge Capital
Management, LLC.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;Hycroft,&#8221; &#8220;Company,&#8221;
 &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us,&#8221; means Hycroft Mining Holding Corporation, a Delaware corporation and its subsidiaries.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;Hycroft Mine&#8221; means the Hycroft Open
Pit Mine, located in Winnemucca, Nevada that produces gold and silver using a heap leach mining process.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;Hycroft Technical Report&#8221; means that
certain Technical Report Summary, Heap Leaching Feasibility Study prepared for the Seller with an effective date of July&#160;31, 2019
by M3 Engineering and Technology Corporation and other qualified persons, prepared in accordance with the requirements of the Modernization
of Property Disclosures for Mining Registrants set forth in subpart 1300 of Regulation S-K.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;IPO&#8221; means the Company&#8217;s initial
public offering, consummated on February&#160;12, 2018, through the sale of 20,800,000 public&#160;units (including 800,000&#160;units
sold pursuant to the underwriters&#8217; partial exercise of their overallotment option) at $10.00 per unit.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;Mudrick Capital&#8221; means Mudrick Capital
Management, L.P., a Delaware limited partnership, an affiliate of sponsor.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;NASDAQ&#8221; means the National Association
of Securities Dealers Automated Quotations Capital Market.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;October 2020 warrants&#8221; means the
warrants issued as part of the Company&#8217;s October 6, 2020 registered public offering of an aggregate of 9,583,334 units, which warrants
are exercisable for $10.50 per share.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;October 2020 Warrant Agreement&#8221; means
that certain warrant agreement dated October 6, 2020 between Hycroft Mining Holding Corporation and Continental Stock Transfer &amp; Trust
Company, as warrant agent.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;PIPE warrants&#8221; means the warrants
to purchase one share of Common Stock at a price of $11.50 per share issued to the Initial Subscribers in the private investment.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;private placement warrants&#8221; means
the warrants issued to sponsor and Cantor in a private placement simultaneously with the closing of the IPO.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;public shares&#8221; means shares of Common
Stock sold as part of the&#160;units in the IPO.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;public warrants&#8221; means the warrants
included in the&#160;units issued in the IPO, where one warrant entitles the holder thereof to purchase one share of Common Stock at an
exercise price of $11.50 per share of Common Stock in accordance with the terms of the Warrant Agreement.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;Purchase Agreement&#8221; means that certain
Purchase Agreement, dated January&#160;13, 2020, as amended on February&#160;26, 2020, by and among the Company, Acquisition Sub and the
Seller.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;Recapitalization Transaction&#8221; means
the transactions contemplated by the Purchase Agreement, the Exchange Agreement and the Second Lien Conversion Agreement consummated on
May&#160;29, 2020.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;SEC&#8221; means the United States Securities
and Exchange Commission.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p>
<!-- Field: Page; Sequence: 8; Value: 2 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->viii<!-- Field: /Sequence --></p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;Securities Act&#8221; means the Securities
Act of 1933, as amended.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;Seller&#8221; means Hycroft Mining Corporation,
a Delaware corporation.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;Seller warrants&#8221; means a warrant
to purchase shares of Common Stock issued pursuant to the Seller Warrant Agreement following the assumption of the Seller Warrant Agreement
by the Company pursuant to the Purchase Agreement and effective as of the consummation of the Recapitalization Transaction.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;Seller Warrant Agreement&#8221; means that
certain warrant agreement, dated as of October&#160;22, 2015, by and between Seller and Computershare Inc., a Delaware corporation, and
its wholly-owned subsidiary Computershare Trust Company, N.A., a federally chartered trust company, collectively as initial warrant agent;
such warrant agreement was assumed by the Company pursuant to the Purchase Agreement and Continental Stock Transfer&#160;&amp; Trust Company,
LLC is the successor warrant agent.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;sponsor&#8221; means Mudrick Capital Acquisition
Holdings LLC, a Delaware limited liability company, which is 100% owned by investment funds and separate accounts managed by Mudrick Capital.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;Warrant Agreement&#8221; means the Warrant
Agreement, dated February&#160;7, 2018, by and between Mudrick Capital Acquisition Corporation and Continental Stock Transfer&#160;&amp;
Trust Company, LLC.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;Whitebox&#8221; means Whitebox Advisors,
LLC.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;Wolverine&#8221; means Wolverine Asset
Management, LLC.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p>
<!-- Field: Page; Sequence: 9; Value: 2 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ix<!-- Field: /Sequence --></p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase"><b><a name="am_004"></a>PROSPECTUS
SUMMARY</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase"><b>&#160;</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>This summary highlights information contained
elsewhere in this prospectus or incorporated by reference herein. It does not contain all the information that you may consider important
in making your investment decision. Therefore, you should read the entire prospectus carefully along with the information incorporated
by reference herein.</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Overview</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are a U.S.-based gold producer that has historically
focused on mining, developing, and exploring properties in the state of Nevada in a safe, environmentally responsible and cost-effective
manner. Gold and silver sales have historically represented 100% of the Seller&#8217;s operating revenues and are expected to represent
100% of our operating revenues in the future. Accordingly, the market prices of gold and silver significantly impact our financial position,
operating results and cash flows.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The mailing address of our principal executive
office is 8181 E. Tufts Ave., Suite 510, Denver, CO 80237. The telephone number of Hycroft is (303) 253-3267.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Company History</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On May 29, 2020, the Company, formerly known as
Mudrick Capital Acquisition Corporation, consummated the transactions contemplated by the Purchase Agreement, dated as of January 13,
2020, by and among the Company, MUDS Acquisition Sub, Inc. (&#8220;Acquisition Sub&#8221;) and Hycroft Mining Corporation (&#8220;Seller&#8221;),
as amended by that certain Amendment to Purchase Agreement, dated as of February 26, 2020 (the &#8220;Purchase Agreement&#8221;). Pursuant
to the Purchase Agreement, Acquisition Sub acquired all of the issued and outstanding equity interests of the direct subsidiaries of Seller
and substantially all of the other assets and assumed substantially all of the liabilities of Seller. In connection with the completion
of the recapitalization transactions contemplated by the Purchase Agreement (the &#8220;Recapitalization Transaction&#8221;), the Company
changed its name from Mudrick Capital Acquisition Corporation to Hycroft Mining Holding Corporation.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Seller was incorporated as Allied Nevada Gold
Corp. under the laws of the State of Delaware on September 14, 2006 and commenced operations on May 10, 2007. Seller suspended mining
operations at the Hycroft Mine on July 8, 2015 to maximize cash flow and minimize spending during Seller&#8217;s restructuring under Chapter
11 of the U.S. Bankruptcy Code and changed its name from Allied Nevada Gold Corp. to Hycroft Mining Corporation on October 9, 2015 in
connection with its restructuring and emergence from bankruptcy proceedings. Seller continued to process and produce gold and silver,
but in 2017, with revenue no longer covering the cost of production, the Hycroft Mine was placed into care and maintenance mode to minimize
expenditures and conserve cash. While in care and maintenance, gold and silver production was a byproduct of maintenance activities.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our Business</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our operating mine, the Hycroft Mine, is an open-pit
heap leach operation located approximately 54 miles west of Winnemucca, Nevada. Mining operations at the Hycroft Mine were restarted in
2019. As part of the restart, Seller, along with M3 Engineering and Technology Corporation (&#8220;M3 Engineering&#8221;), in conjunction
with SRK Consulting (U.S.), Inc. (&#8220;SRK&#8221;), completed the Hycroft Technical Report Summary, Heap Leaching Feasibility Study,
prepared in accordance with the requirements of the Modernization of Property Disclosures for Mining Registrants, set forth in subpart
1300 of Regulation S-K, with an effective date of July 31, 2019 (the &#8220;Hycroft Technical Report&#8221;) for our proprietary two-stage
heap oxidation and leach process for sulfide ore. During the year ended December 31, 2020 we sold 24,892 ounces of gold and 136,238 ounces
of silver. As of December 31, 2020, the Hycroft Mine had proven and probable mineral reserves of 11.9 million ounces of gold and 478.5
million ounces of silver, which are contained in oxide, transitional, and sulfide ores. We currently recover gold and silver through our
heap leach process operations, while we continue to study and conduct testing of commercial production using our proprietary two-stage
heap oxidation and leach process.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p>
<!-- Field: Page; Sequence: 10; Options: NewSection; Value: 1 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<!-- Field: Split-Segment; Name: 1 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our Properties</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">All of our mining properties are located in Nevada.
We currently have one operating property, namely the Hycroft Mine as discussed herein.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risk Factors</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">An investment in our securities common stock
involves substantial risk. The occurrence of one or more of the events or circumstances described in the section entitled &#8220;<i>Risk
Factors</i>,&#8221; alone or in combination with other events or circumstances, may have a material adverse effect on our business, cash
flows, financial condition and results of operations. Important factors and risks that could cause actual results to differ materially
from those in the forward-looking statements include, among others:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Industry-related risks including:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Fluctuations in the price of gold and silver;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Uncertainties concerning estimates of mineral reserves and mineral resources;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Uncertainties relating to the COVID-19 pandemic;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">The intense competition within the mining industry;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">The inherently hazardous nature of mining activities, including environmental
    risks;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Our insurance may not be adequate to cover all risks associated with our
    business, or cover the replacement costs of our assets or may not be available for some risks;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Potential effects on our operations of U.S. federal and state governmental
    regulations, including environmental regulation and permitting requirements;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Cost of compliance with current and future government regulations;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Uncertainties relating to obtaining or retaining approvals and permits
    from governmental regulatory authorities;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Potential challenges to title in our mineral properties;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Risks associated with proposed legislation in Nevada that could significantly
    increase the costs or taxation of our operations; and</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Changes to the climate and regulations and pending legislation regarding
    climate change.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Business-related risks including:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Risks related to our liquidity and going concern considerations;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Risks related to our ability to raise capital on favorable terms or at
    all;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Risks related to the proprietary two-stage heap oxidation and leach process
    at the Hycroft Mine and estimates of production;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Our ability to achieve our estimated production and sales rates and stay
    within our estimated operating and production costs and capital expenditure projections;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<!-- Field: Page; Sequence: 11; Options: NewSection; Value: 2 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Risks related to a decline in our gold and silver production;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Our ability to successfully eliminate or meaningfully reduce processing
    and mining constraints; the results of our planned 2021 technical efforts and how the data resulting from such efforts could adversely
    impact processing technologies applied to our ore, future operations and profitability;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Risks related to our reliance on one mine with a new process;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Risks related to our limited experience with a largely untested process
    of oxidizing and heap leaching sulfide ore;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Uncertainties and risks related to our reliance on contractors and consultants;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Availability and cost of equipment, supplies, energy, or commodities;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">The commercial success of, and risks relating to, our development activities;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Risks related to slope stability;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Risks related to our substantial indebtedness, including cross acceleration
    and our ability to generate sufficient cash to service our indebtedness;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Uncertainties resulting from the possible incurrence of operating and net
    losses in the future;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Uncertainties related to our ability to replace and expand our mineral
    reserves;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">The costs related to our land reclamation requirements;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">The loss of key personnel or our failure to attract and retain personnel;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Risks related to technology systems and security breaches;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Any failure to remediate and possible litigation as a result of a material
    weakness in our internal controls over financial reporting; and</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Risks that our principal stockholders will be able to exert significant
    influence over matters submitted to stockholders for approval.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Risks related to our Common Stock and warrants, including</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Volatility in the price of our Common Stock and warrants;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Potential declines in the value of our Common Stock and warrants due to
    substantial future sales of our Common Stock and/or warrants;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Risks that warrants may expire worthless;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">The valuation of our 5-Year Private Warrants could increase the volatility
    of our net income (loss);</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Anti&#8211;takeover provisions could make a third-party acquisition of
    us difficult; and</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Risks related to limited access to our financial information, as we have
    elected to take advantage of the disclosure requirement exemptions granted to emerging growth companies and smaller reporting companies.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">You should carefully review and consider the
risk factors set forth under the section entitled &#8220;<i>Risk Factors</i>&#8221; beginning on page 6 of this prospectus.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>
<!-- Field: Page; Sequence: 12; Value: 2 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Implications of Being an Emerging Growth Company</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We qualify as an &#8220;emerging growth company&#8221;
as defined in the Jumpstart our Business Startups Act of 2012, or the &#8220;JOBS Act.&#8221; An emerging growth company may take advantage
of specified reduced requirements and is relieved of certain other significant requirements that are otherwise generally applicable to
public companies. As an emerging growth company:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">we may present only two years of audited financial statements and only
    two years of related Management&#8217;s Discussion &amp; Analysis of Financial Condition and Results of Operations;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">we are exempt from the requirement to obtain an attestation report from
    our auditors on the assessment of our internal control over financial reporting pursuant to the Sarbanes-Oxley Act of 2002;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">we are permitted to provide less extensive disclosure about our executive
    compensation arrangements; and</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">we are not required to give our stockholders non-binding votes on executive
    compensation or &#8220;golden parachute&#8221; arrangements.&#160;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We may take advantage of these provisions for
up to five full fiscal years or such earlier time that we are no longer an emerging growth company. We may choose to take advantage of
some but not all of these reduced burdens. We would cease to be an emerging growth company if we have more than $1 billion in annual
revenues, have more than $700 million in market value of our shares of common stock held by non-affiliates, or issue more than $1 billion
of non-convertible debt over a three-year period. The Company has elected not to opt out of the extended transition period which means
that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an
emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This
may make comparison of the Company&#8217;s financial statements with another public company which is neither an emerging growth company
nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential
differences in accounting standards used.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our Smaller Reporting Company Status</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are also currently a &#8220;smaller reporting
company,&#8221; meaning that as of the last business day of our most recent second fiscal quarter, we had a public float of less than
$250 million or annual revenues of less than $100 million. In the event that we are still considered a &#8220;smaller reporting company&#8221;
at such time as we cease being an &#8220;emerging growth company,&#8221; the disclosure we will be required to provide in our SEC filings
will increase, but will still be less than it would be if we were not considered either an &#8220;emerging growth company&#8221; or a
 &#8220;smaller reporting company.&#8221; Specifically, similar to &#8220;emerging growth companies,&#8221; &#8220;smaller reporting companies&#8221;
are able to provide simplified executive compensation disclosures in their filings; may be exempt from the provisions of Section 404(b)
of the Sarbanes-Oxley Act requiring that independent registered public accounting firms provide an attestation report on the effectiveness
of internal control over financial reporting; and have certain other decreased disclosure obligations in their SEC filings.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Accordingly, the information that we provide
you may be different than what you may receive from other public companies in which you hold equity interests.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<!-- Field: Page; Sequence: 13; Value: 2 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Corporate Information</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We were incorporated on August 28, 2017 as a
Delaware corporation under the name &#8220;Mudrick Capital Acquisition Corporation&#8221; and formed for the purpose of effecting a merger,
capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
On May 29, 2020, in connection with the consummation of the Recapitalization Transaction, we changed our name to &#8220;Hycroft Mining
Holding Corporation&#8221;.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our principal executive offices are located at
8181 E. Tufts Ave., Suite 510, Denver, Colorado, and our telephone number is (303) 253-3267. Our website is www.hycroftmining.com. The
information found on, or that can be accessed from or that is hyperlinked to, our website is not part of this prospectus.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p>
<!-- Field: Page; Sequence: 14; Value: 2 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><a name="a_001"></a>RISK FACTORS</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase"><b>&#160;</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">An investment in our securities common stock
involves substantial risk. The occurrence of one or more of the events or circumstances described in the section entitled &#8220;<i>Risk
Factors</i>,&#8221; alone or in combination with other events or circumstances, may have a material adverse effect on our business, cash
flows, financial condition and results of operations. Please carefully consider the risk factors described in Part 1, Item 1A. Risk Factors
of Hycroft&#8217;s Amended <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1718405/000171840521000029/hymc-20201231.htm" style="-sec-extract: exhibit">Annual
Report on Form 10-K/A for the year ended December 31, 2020 filed on May 14, 2021</a> with the SEC, which is incorporated by reference
herein, and may be amended, supplemented or superseded from time to time by other reports we file with the SEC in the future, including,
any subsequently filed Quarterly Report on Form 10-Q or any Current Report on Form 8-K, <font style="background-color: white">together
with all of the other information appearing in or incorporated by reference into this prospectus and any applicable prospectus supplement</font>.
Before making investment decisions, you should carefully consider these risks as well as other information we include or incorporate
by reference in this prospectus or include in any applicable prospectus supplement. Additional risks and uncertainties not presently
known to us or that we currently deem immaterial may also impair our business operations.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase"><b><a name="a_002"></a>USE
OF PROCEEDS</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase"><b>&#160;</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are not selling any securities under this
prospectus and we will not receive any proceeds from the sale of securities by the Selling Securityholders, although we could receive
up to approximately $590 million assuming the exercise of all of the outstanding public warrants, private placement warrants, forward
purchase warrants, PIPE warrants, October 2020 warrants and Seller warrants, to the extent such warrants are exercised for cash. Any
amounts we receive from such exercises will be used for working capital and other general corporate purposes. The holders of the warrants
are not obligated to exercise the warrants and we cannot assure you that the holders of the warrants will choose to exercise any or all
of the warrants.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase"><b><a name="a_003"></a>WHERE
YOU CAN FIND MORE INFORMATION</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase"><b>&#160;</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have filed with the SEC a registration statement
on Form&#160;S-3 under the Securities Act with respect to the securities offered by this prospectus. This prospectus, which forms a part
of such registration statement, does not contain all of the information included in the registration statement. For further information
pertaining to us and our securities, you should refer to the registration statement and to its exhibits. The registration statement has
been filed electronically and may be obtained in any manner listed below. Whenever we make reference in this prospectus to any of our
contracts, agreements or other documents, the references are not necessarily complete. If a contract or document has been filed as an
exhibit to the registration statement or a report we file under the Exchange Act, you should refer to the copy of the contract or document
that has been filed. Each statement in this prospectus relating to a contract or document filed as an exhibit to a registration statement
or report is qualified in all respects by the filed exhibit. You may review a copy of the registration statement through the SEC&#8217;s
website at www.sec.gov.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We file annual, quarterly and current reports,
proxy statements and other information with the SEC. Our SEC filings are available to the public over the internet at the SEC&#8217;s
website at www.sec.gov and on our website at www.hycroftmining.com. The information found on, or that can be accessed from or that is
hyperlinked to, our website is not part of this prospectus. You may inspect a copy of the registration statement through the SEC&#8217;s
website, as provided herein. Copies of any materials we file with the SEC can be obtained at the SEC&#8217;s website, www.sec.gov and
on our website at www.hycroftmining.com.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<!-- Field: Page; Sequence: 15; Value: 2 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="text-transform: uppercase"><b>&#160;</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase"><b><a name="a_004"></a>SELLING
SECURITYHOLDERS</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase"><b>&#160;</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Selling Securityholders may from time to
time offer and sell any or all of our securities set forth below pursuant to this prospectus. When we refer to &#8220;Selling Securityholders&#8221;
in this prospectus, we mean the persons listed in the table below, and the pledgees, donees, permitted transferees, assignees, successors
and others who later come to hold any of the Selling Securityholders&#8217; interests in our securities other than through a public sale.
The following table sets forth certain information with respect to beneficial ownership of our Common Stock as of June 17, 2021 by the
Selling Securityholders. This information has been obtained from the Selling Securityholders or in Schedules 13G or 13D and other public
documents filed with the SEC.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following table sets forth:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">the name of the Selling Securityholders for whom we are registering shares
    of Common Stock and warrants for resale to the public,</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">the number of shares of Common Stock and warrants that the Selling Securityholders
    beneficially owned prior to the offering for resale of the securities under this prospectus,</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">the number of shares of Common Stock and warrants that may be offered for
    resale for the account of the Selling Securityholders pursuant to this prospectus, and</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 24px; font-size: 10pt"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">the number and percentage of shares to be beneficially owned by the Selling
    Securityholders after the offering of the resale securities (assuming all of the offered shares of Common Stock and warrants are
    sold by the Selling Securityholders).</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Shares of Common Stock</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td>
<td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Beneficial<br/>
    Ownership<br/>
    Before<br/>
    the Offering</b></font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td>
<td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Shares to be<br/>
    Sold in<br/>
    the Offering</b></font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td>
<td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Beneficial<br/>
    Ownership <br/>
    After&#160;&#160;<br/>
    the Offering</b></font></td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="border-bottom: black 1pt solid; width: 52%; text-align: justify"><font style="font-size: 10pt"><b>Name of Selling Securityholder</b></font></td>
<td style="width: 1%; text-align: justify">&#160;</td>
<td style="border-bottom: black 1pt solid; width: 8%; text-align: center"><font style="font-size: 10pt"><b>Number of<br/>

    Shares</b></font></td>
<td style="width: 1%; text-align: justify">&#160;</td>
<td style="border-bottom: black 1pt solid; width: 5%; text-align: center"><font style="font-size: 10pt"><b>%<sup>(1)</sup></b></font></td>
<td style="width: 1%; text-align: justify">&#160;</td>
<td style="width: 1%; text-align: justify">&#160;</td>
<td style="border-bottom: black 1pt solid; width: 8%; text-align: center"><font style="font-size: 10pt"><b>Number of<br/>

    Shares</b></font></td>
<td style="width: 1%; text-align: justify">&#160;</td>
<td style="border-bottom: black 1pt solid; width: 5%; text-align: center"><font style="font-size: 10pt"><b>%<sup>(1)</sup></b></font></td>
<td style="width: 1%; text-align: justify">&#160;</td>
<td style="width: 1%; text-align: justify">&#160;</td>
<td style="border-bottom: black 1pt solid; width: 8%; text-align: center"><font style="font-size: 10pt"><b>Number of<br/>

    Shares</b></font></td>
<td style="width: 1%; text-align: justify">&#160;</td>
<td style="border-bottom: black 1pt solid; width: 5%; text-align: center"><font style="font-size: 10pt"><b>%<sup>(1)</sup></b></font></td>
<td style="width: 1%; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="text-align: justify"><font style="font-size: 10pt">Mudrick Capital Management, L.P.<sup>(2)</sup></font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">37,730,034</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">51.5</font></td>
<td style="text-align: justify"><font style="font-size: 10pt">%</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">37,730,034</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">51.5</font></td>
<td style="text-align: justify"><font style="font-size: 10pt">%</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">0</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="text-align: justify"><font style="font-size: 10pt">Whitebox Advisors LLC<sup>(3)</sup></font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">12,856,334</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">21.1</font></td>
<td style="text-align: justify"><font style="font-size: 10pt">%</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">12,856,334</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">21.1</font></td>
<td style="text-align: justify"><font style="font-size: 10pt">%</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">0</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="text-align: justify"><font style="font-size: 10pt">Highbridge Capital Management, LLC<sup>(4)</sup></font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">6,982,667</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">11.7</font></td>
<td style="text-align: justify"><font style="font-size: 10pt">%</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">8,336,532</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">13.6</font></td>
<td style="text-align: justify"><font style="font-size: 10pt">%</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">0</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="text-align: justify"><font style="font-size: 10pt">Aristeia Capital, L.L.C.<sup>(5)</sup></font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">5,908,351</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">9.8</font></td>
<td style="text-align: justify"><font style="font-size: 10pt">%</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">8,233,317</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">13.1</font></td>
<td style="text-align: justify"><font style="font-size: 10pt">%</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">0</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="text-align: justify"><font style="font-size: 10pt">Wolverine Asset Management, LLC<sup>(6)</sup></font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">1,409,536</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">2.3</font></td>
<td style="text-align: justify"><font style="font-size: 10pt">%</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">1,409,536</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">2.3</font></td>
<td style="text-align: justify"><font style="font-size: 10pt">%</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">0</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="text-align: justify"><font style="font-size: 10pt">Sprott Private Resource Lending II (Collector), LP<sup>(7)</sup></font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">437,940</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">437,940</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">0</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="text-align: justify"><font style="font-size: 10pt">Cantor Fitzgerald &amp; Co<sup>(8)</sup></font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">732,810</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">1.2</font></td>
<td style="text-align: justify"><font style="font-size: 10pt">%</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">732,810</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">1.2</font></td>
<td style="text-align: justify"><font style="font-size: 10pt">%</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">0</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="text-align: justify"><font style="font-size: 10pt">Prisma Pelican Fund<sup>(9)</sup></font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">31,604</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">31,604</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">0</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="text-align: justify"><font style="font-size: 10pt">Ninepoint Credit Opportunities Fund<sup>(10)</sup></font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">4,515</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">4,515</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">0</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="text-align: justify"><font style="font-size: 10pt">Natural Resource Income Investing Limited Partnership<sup>(11)</sup></font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">9,030</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">9,030</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">0</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="text-align: justify"><font style="font-size: 10pt">Sprott Private Resource Streaming and Royalty (Collector), LP.<sup>(12)</sup></font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">13,545</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">13,545</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">0</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="text-align: justify"><font style="font-size: 10pt">Timothy Daileader </font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">6,493</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">6,493</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">0</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="text-align: justify"><font style="font-size: 10pt">Brian Kushner </font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">6,493</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">6,493</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">0</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="text-align: justify"><font style="font-size: 10pt">Dennis Stogsdill</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">6,493</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">6,493</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">0</font></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td style="text-align: justify">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0">*&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less than 1%</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 0px">&#160;</td>
<td style="width: 30px"><font style="font-size: 10pt">(1)</font></td>
<td><font style="font-size: 10pt">Based on 59,964,980 shares of Common Stock issued and outstanding on June 23, 2021.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0"></p>
<!-- Field: Page; Sequence: 16; Value: 2 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0">&#160;&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 0px">&#160;</td>
<td style="width: 30px"><font style="font-size: 10pt">(2)</font></td>
<td><font style="font-size: 10pt">Includes: (i) 14,684,202 shares of Common Stock (including 4,604,204 shares of Common Stock underlying
    warrants) held by Mudrick Distressed Opportunity Fund Global L.P.; (ii) 4,125,030 shares of Common Stock (including 1,530,893 shares
    of Common Stock underlying warrants) held by Mudrick Distressed Opportunity Drawdown Fund, L.P.; (iii) 3,873,868 shares of Common
    Stock (including 1,717,473 shares of Common Stock underlying warrants) held by Mudrick Distressed Opportunity Drawdown Fund II, L.P.;
    (iv) 49,132 shares of Common Stock (including 14,722 shares of Common Stock underlying warrants) held by Mudrick Distressed Senior
    Secured Fund Global, L.P.; (v) 1,244,498 shares of Common Stock (including 622,249 shares of Common Stock underlying warrants) held
    by Mudrick Distressed Opportunity Drawdown Fund II SC, L.P.; and (vi) 13,753,304 shares of Common Stock (including 4,833,710 shares
    of Common Stock underlying warrants) held by certain accounts managed by Mudrick Capital Management, L.P. (collectively the &#8220;Mudrick
    Funds&#8221;). Mudrick Capital Management, L.P. is the investment manager of the Mudrick Funds other than the Sponsor and is the
    managing member of the Sponsor. Mudrick Capital Management, L.P. holds voting and dispositive power over the shares of Common Stock
    held by the Mudrick Funds and the Sponsor. Mudrick Capital Management, LLC is the general partner of Mudrick Capital Management,
    L.P., and Jason Mudrick is the sole member of Mudrick Capital Management, LLC. As such, Mudrick Capital Management, L.P., Mudrick
    Capital Management, LLC and Jason Mudrick may be deemed to have beneficial ownership of the shares of Common Stock held by the Mudrick
    Funds. Each such entity or person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary
    interest they may have therein, directly or indirectly. The business address of such holders is 527 Madison Avenue, 6th Floor, New
    York, New York 10022.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 0px">&#160;</td>
<td style="width: 30px"><font style="font-size: 10pt">(3)</font></td>
<td><font style="font-size: 10pt">Includes (i) 1,999,914 shares of Common Stock held by Whitebox Asymmetric Partners, LP (including
    139,691 shares of Common Stock underlying warrants); (ii) 5,136,986 shares of Common Stock held by Whitebox Credit Partners, LP (including
    371,598 shares of Common Stock underlying warrants); (iii) 1,276,623 shares of Common Stock held by Whitebox Institutional Partners,
    LP (including 89,476 shares of Common Stock underlying warrants); and (iv) 4,442,811 shares of Common Stock held by Whitebox Multi-Strategy
    Partners, LP (including 312,252 shares of Common Stock underlying warrants). Whitebox Advisors LLC is the investment manager of Whitebox
    Asymmetric Partners, LP, Whitebox Credit Partners, LP, Whitebox Institutional Partners, LP, Whitebox Multi-Strategy Partners, LP
    (collectively, the &#8220;Whitebox Funds&#8221;) and holds voting and disposable power over the shares of the Company held by the
    Whitebox Funds. Whitebox Advisors LLC is owned by Robert Vogel, Paul Twitchell, Jacob Mercer, and Paul Roos and such individuals
    disclaim beneficial ownership of the securities referenced herein except to the extent of its or his direct or indirect economic
    interest in Whitebox Advisors LLC or such Whitebox Funds. The address of these persons is 3033 Excelsior Blvd., Suite 500, Minneapolis,
    Minnesota 55416.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 0px">&#160;</td>
<td style="width: 30px"><font style="font-size: 10pt">(4)</font></td>
<td><font style="font-size: 10pt">Ownership before the offering includes (i) 2,385,604 shares of Common Stock held by Highbridge
    Tactical Credit Master Fund, L.P. ("TCF"); and (ii) 4,597,063 shares of Common Stock held by Highbridge MSF International
    Ltd. ("<i>MSF</i>" and, together with TCF, the "Highbridge Funds"). The foregoing figures for ownership before
    the offering exclude 423,996 shares of Common Stock underlying warrants held by TCF and 929,869 shares of Common Stock underlying
    warrants held by MSF that are not presently exercisable due to the effect of a beneficial ownership limitation blocker but which
    are included as shares to be sold in the offering. These shares of Common Stock underlying warrants are included as part of the shares
    registered to be sold in the offering. Highbridge Capital Management, LLC ("HCM"), the trading manager of the Highbridge
    Funds, may be deemed to be the beneficial owner of the shares held by the Highbridge Funds. Jonathan Segal and Jason Hempel are responsible
    for the investment and voting decisions made by HCM with respect to the shares held by MSF and TCF. The Highbridge Funds and the
    foregoing individuals disclaim any beneficial ownership of these shares. The business address of HCM is 277 Park Avenue, 23rd Floor,
    New York, NY 10172 and the business address of the Highbridge Funds is c/o HedgeServ (Cayman) Ltd., Cricket Square, Floor 6, George
    Town, Grand Cayman KY1-1104, Cayman Islands.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 0px">&#160;</td>
<td style="width: 30px"><font style="font-size: 10pt">(5)</font></td>
<td><font style="font-size: 10pt">Ownership before the offering includes (i) 2,291,149 shares of Common Stock (including 112,622
    shares of Common Stock underlying warrants) held by ALSV Limited; (ii) 157,348 shares of Common Stock (including 25,383 shares of
    Common Stock underlying warrants) held by Windermere Ireland Fund PLC; (iii) 2,625,619 shares of Common Stock (including 138,268
    shares of Common Stock underlying warrants) held by APSV, LLC; (iv) 468,652 shares of Common Stock (including 92,467 shares of Common
    Stock underlying warrants) held by ASIG International Limited; and (v) 365,583 shares of Common Stock (including 19,252 shares of
    Common Stock underlying warrants) held by DS Liquid Div RVA ARST, LLC (collectively, the &#8220;Aristeia Funds&#8221;). The foregoing
    figures for ownership before the offering exclude (A) 674,868 shares of Common Stock underlying warrants held by ALSV Limited; (B)
    152,104 shares of Common Stock underlying warrants held by Windermere Ireland Fund PLC; (C) 828,543 shares of Common Stock underlying
    warrants held by APSV, LLC; (D) 554,088 shares of Common Stock underlying warrants held by ASIG International Limited; and (E) 115,363
    shares of Common Stock underlying warrants held by DS Liquid Div RVA ARST, LLC, that are not presently exercisable due to the effect
    of a beneficial ownership limitation blocker but which are included as shares to be sold in the offering. These shares of Common
    Stock underlying warrants are included as part of the shares registered to be sold in the offering. Aristeia Capital, L.L.C. (&#8220;Aristeia&#8221;)
    may be deemed the beneficial owner of the securities described herein in its capacity as the investment manager of the Aristeia Funds,
    which are the holders of such securities. As investment manager of each Aristeia Fund, Aristeia has voting and investment control
    with respect to the securities held by each Aristeia Fund. Anthony M. Frascella and William R. Techar are the Co-Chief Investment
    Officers of Aristeia. Each of Aristeia and such individuals disclaim beneficial ownership of the securities referenced herein except
    to the extent of its or his direct or indirect economic interest in the Aristeia Funds. The business address of such holders is One
    Greenwich Plaza, Third Floor, Greenwich, Connecticut 06830.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<!-- Field: Page; Sequence: 17; Value: 2 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 0px">&#160;</td>
<td style="width: 30px"><font style="font-size: 10pt">(6)</font></td>
<td><font style="font-size: 10pt">Includes 1,409,536 shares of Common Stock (including 169,985 shares of Common Stock underlying
    warrants) held by Wolverine Flagship Fund Trading Limited (the &#8220;WF Fund&#8221;). Wolverine Asset Management, LLC (&#8220;WAM&#8221;)
    is the investment manager to WF Fund and has voting and investment power over these securities. The sole member and manager of WAM
    is Wolverine Holdings, L.P. (&#8220;Wolverine Holdings&#8221;). Robert R. Bellick and Christopher L. Gust may be deemed to control
    Wolverine Trading Partners, Inc. (&#8220;WTP&#8221;), the general partner of Wolverine Holdings. Each of Robert R. Bellick, Christopher
    L. Gust, Wolverine Holdings, WTP, and WAM disclaims beneficial ownership of the securities held by the WF Fund. The business address
    of such holders is 175 W. Jackson Blvd., Suite 340, Chicago, Illinois 60604.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 0px">&#160;</td>
<td style="width: 30px"><font style="font-size: 10pt">(7)</font></td>
<td><font style="font-size: 10pt">Sprott Resource Lending Corp. is the investment manager of Sprott Private Resource Lending II (Collector),
    LP and may be deemed to be the beneficial owner of the shares held by Sprott Private Resource Lending II (Collector), LP . Peter
    Grosskopf, Jim Grosdanis, Narinder Nagra and Varinder Bhathal are responsible for the investment and voting decisions made by Sprott
    Resource Lending Corp. The business address of such holders is 200 Bay Street, Suite 2600, Toronto, ON, Canada, M5J 2J1.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 0px">&#160;</td>
<td style="width: 30px"><font style="font-size: 10pt">(8)</font></td>
<td><font style="font-size: 10pt">Includes 688,415 shares of common stock underlying warrants. The business address of Cantor Fitzgerald
    &amp; Co. is 110 East 59th Street, New York, NY 10022.&#160;&#160;Howard W. Lutnick, through indirect beneficial ownership of the
    general partners of Cantor Fitzgerald &amp; Co., has voting and investment control over the shares. Mr. Lutnick disclaims beneficial
    ownership of the shares except to the extent of any pecuniary interest therein.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 0px">&#160;</td>
<td style="width: 30px"><font style="font-size: 10pt">(9)</font></td>
<td><font style="font-size: 10pt">Prisma Capital Partners LP is the investment manager of Prisma Pelican Fund LLC and may be deemed
    to be the beneficial owner of the shares held by Prisma Pelican Fund LLC. The business address of such holders is 9 West 57th Street,
    Suite 2600, New York, NY 10019.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 0px">&#160;</td>
<td style="width: 30px"><font style="font-size: 10pt">(10)</font></td>
<td><font style="font-size: 10pt">Ninepoint Partners LP is the investment manager of Ninepoint Credit Income Opportunities Fund and
    may be deemed to be the beneficial owner of the shares held by Ninepoint Credit Income Opportunities Fund. The business address of
    such holders is 200 Bay Street, Suite 2700, Toronto, ON, Canada, M5J 2J2.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 0px">&#160;</td>
<td style="width: 30px"><font style="font-size: 10pt">(11)</font></td>
<td><font style="font-size: 10pt">Resource Capital Investment Corp. is the investment manager of Natural Resource Investing LP and
    may be deemed to be the beneficial owner of the shares held by Natural Resource Investing LP. Arthur Rule, Varinder Bhathal and Thomas
    Ulrich are responsible for the investment and voting decisions made by Resource Capital Investment Corp. The business address of
    such holders is 1910 Palomar Point Way, Suite 200, Carlsbad, CA 92008.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 0px">&#160;</td>
<td style="width: 30px"><font style="font-size: 10pt">(12)</font></td>
<td><font style="font-size: 10pt">Sprott Resource Streaming and Royalty Corp. is the investment manager of Sprott Private Resource
    Streaming and Royalty (Collector), LP and may be deemed to be the beneficial owner of the shares held by Sprott Private Resource
    Streaming and Royalty (Collector), LP. Michael Harrison and Varinder Bhathal are responsible for the investment and voting decisions
    made by Sprott Resource Streaming and Royalty Corp. Michael Harrison disclaims beneficial ownership of such shares. The business
    address of such holders is 200 Bay Street, Suite 2600, Toronto, ON, Canada, M5J 2J1.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<!-- Field: Page; Sequence: 18; Value: 2 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Warrants</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="text-align: justify">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Beneficial<br/>
    Ownership Before<br/>
    the Offering</b></font></td>
<td>&#160;</td>
<td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Warrants to be <br/>
    Sold<br/>
    in the Offering</b></font></td>
<td>&#160;</td>
<td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Beneficial<br/>
    Ownership<br/>
    After<br/>
    the Offering</b></font></td></tr>
<tr style="vertical-align: bottom">
<td style="border-bottom: black 1pt solid; width: 52%; text-align: justify"><font style="font-size: 10pt"><b>Name of Selling Securityholder</b></font></td>
<td style="width: 1%">&#160;</td>
<td style="border-bottom: black 1pt solid; width: 10%; text-align: center"><font style="font-size: 10pt"><b>Number of<br/>

    Warrants</b></font></td>
<td style="width: 1%">&#160;</td>
<td style="border-bottom: black 1pt solid; width: 5%; text-align: center"><font style="font-size: 10pt"><b>%<sup>(1)</sup></b></font></td>
<td style="width: 1%">&#160;</td>
<td style="border-bottom: black 1pt solid; width: 10%; text-align: center"><font style="font-size: 10pt"><b>Number of<br/>

    Warrants</b></font></td>
<td style="width: 1%">&#160;</td>
<td style="border-bottom: black 1pt solid; width: 5%; text-align: center"><font style="font-size: 10pt"><b>%<sup>(1)</sup></b></font></td>
<td style="width: 1%">&#160;</td>
<td style="border-bottom: black 1pt solid; width: 10%; text-align: center"><font style="font-size: 10pt"><b>Number of
    <br/>
Warrants</b></font></td>
<td style="width: 1%">&#160;</td>
<td style="border-bottom: black 1pt solid; width: 2%; text-align: center"><font style="font-size: 10pt"><b>%<sup>(1)</sup></b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="text-align: justify"><font style="font-size: 10pt">Mudrick Capital Management, L.P.<sup>(2)</sup></font></td>
<td>&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">13,323,251</font></td>
<td>&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">30.4</font></td>
<td style="text-align: justify"><font style="font-size: 10pt">%</font></td>
<td style="text-align: right"><font style="font-size: 10pt">13,323,251</font></td>
<td>&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">30.4</font></td>
<td style="text-align: justify"><font style="font-size: 10pt">%</font></td>
<td style="text-align: right"><font style="font-size: 10pt">0</font></td>
<td>&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="text-align: justify"><font style="font-size: 10pt">Whitebox Advisors LLC<sup>(3)</sup></font></td>
<td>&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">913,017</font></td>
<td>&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">2.1</font></td>
<td style="text-align: justify"><font style="font-size: 10pt">%</font></td>
<td style="text-align: right"><font style="font-size: 10pt">913,017</font></td>
<td>&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">2.1</font></td>
<td style="text-align: justify"><font style="font-size: 10pt">%</font></td>
<td style="text-align: right"><font style="font-size: 10pt">0</font></td>
<td>&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="text-align: justify"><font style="font-size: 10pt">Highbridge Capital Management, LLC<sup>(4)</sup></font></td>
<td>&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">1,353,865</font></td>
<td>&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">3.1</font></td>
<td style="text-align: justify"><font style="font-size: 10pt">%</font></td>
<td style="text-align: right"><font style="font-size: 10pt">1,353,865</font></td>
<td>&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">3.1</font></td>
<td style="text-align: justify"><font style="font-size: 10pt">%</font></td>
<td style="text-align: right"><font style="font-size: 10pt">0</font></td>
<td>&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="text-align: justify"><font style="font-size: 10pt">Aristeia Capital, L.L.C.<sup>(5)</sup></font></td>
<td>&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">2,712,958</font></td>
<td>&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">6.2</font></td>
<td style="text-align: justify"><font style="font-size: 10pt">%</font></td>
<td style="text-align: right"><font style="font-size: 10pt">2,712,958</font></td>
<td>&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">6.2</font></td>
<td style="text-align: justify"><font style="font-size: 10pt">%</font></td>
<td style="text-align: right"><font style="font-size: 10pt">0</font></td>
<td>&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="text-align: justify"><font style="font-size: 10pt">Wolverine Asset Management, LLC<sup>(6)</sup></font></td>
<td>&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">169,985</font></td>
<td>&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td>&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">169,985</font></td>
<td>&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td>
<td>&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">0</font></td>
<td>&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="text-align: justify"><font style="font-size: 10pt">Cantor Fitzgerald &amp; Co<sup>(7)</sup></font></td>
<td>&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">688,415</font></td>
<td>&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">1.6</font></td>
<td style="text-align: justify"><font style="font-size: 10pt">%</font></td>
<td style="text-align: right"><font style="font-size: 10pt">688,415</font></td>
<td>&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">1.6</font></td>
<td style="text-align: justify"><font style="font-size: 10pt">%</font></td>
<td style="text-align: right"><font style="font-size: 10pt">0</font></td>
<td>&#160;</td>
<td style="text-align: right"><font style="font-size: 10pt">*</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td><font style="font-size: 10pt">* Less than 1%</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 30px"><font style="font-size: 10pt">(1)</font></td>
<td><font style="font-size: 10pt">Based on 43,873,232 warrants issued and outstanding on June 23, 2021 of which 34,289,898 warrants
    have an exercise price of $11.50 per share and 9,583,334 warrants have an exercise price of $10.50 per share but excluding the Seller
    warrants which are significantly out of the money with an exercise price of $40.31 per share.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 30px"><font style="font-size: 10pt">(2)</font></td>
<td><font style="font-size: 10pt">Includes (i) 4,604,204 warrants held by Mudrick Distressed Opportunity Fund Global L.P.; (ii) 1,530,893
    warrants held by Mudrick Distressed Opportunity Drawdown Fund, L.P.; (iii) 1,717,473 warrants held by Mudrick Distressed Opportunity
    Drawdown Fund II, L.P.; (iv) 14,722 warrants held by Mudrick Distressed Senior Secured Fund Global, L.P.; (v) 622,249 warrants held
    by Mudrick Distressed Opportunity Drawdown Fund II SC, L.P.; and (vi) 4,833,710 warrants held by certain accounts managed by Mudrick
    Capital Management, L.P. (collectively, the &#8220;Mudrick Funds&#8221;). Mudrick Capital Management, L.P. is the investment manager
    of the Mudrick Funds other than the Sponsor and is the managing member of the Sponsor. Mudrick Capital Management, L.P. holds voting
    and dispositive power over the securities held by the Mudrick Funds. Mudrick Capital Management, LLC is the general partner of Mudrick
    Capital Management, L.P., and Jason Mudrick is the sole member of Mudrick Capital Management, LLC. As such, Mudrick Capital Management,
    L.P., Mudrick Capital Management, LLC and Jason Mudrick may be deemed to have beneficial ownership of the warrants held by the Mudrick
    Funds. Each such entity or person disclaims any beneficial ownership of the reported warrants other than to the extent of any pecuniary
    interest they may have therein, directly or indirectly. The business address of such holders is 527 Madison Avenue, 6th Floor, New
    York, New York 10022.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 30px"><font style="font-size: 10pt">(3)</font></td>
<td><font style="font-size: 10pt">Includes (i) 139,691 warrants held by Whitebox Asymmetric Partners, LP; (ii) 371,598 warrants held
    by Whitebox Credit Partners, LP; (iii) 89,476 warrants held by Whitebox Institutional Partners, LP; and (iv) 312,252 warrants held
    by Whitebox Multi-Strategy Partners, LP. Whitebox Advisors LLC is the investment manager of the Whitebox Funds and holds voting and
    disposable power over the warrants of the Company held by the Whitebox Funds. Whitebox Advisors LLC is owned by Robert Vogel, Paul
    Twitchell, Jacob Mercer, and Paul Roos and such individuals disclaim beneficial ownership of the securities referenced herein except
    to the extent of its or his direct or indirect economic interest in Whitebox Advisors LLC or such Whitebox Funds. The address of
    these persons is 3033 Excelsior Blvd., Suite 500, Minneapolis, Minnesota 55416.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 30px"><font style="font-size: 10pt">(4)</font></td>
<td><font style="font-size: 10pt">Includes (i) 423,996 warrants held by TCF and (ii) 929,869 warrants held by MSF. HCM, the trading
    manager of the Highbridge Funds, may be deemed to be the beneficial owner of the warrants held by the Highbridge Funds. Jonathan
    Segal and Jason Hempel are responsible for the investment and voting decisions made by HCM with respect to the warrants held by MSF
    and TCF. The Highbridge Funds and the foregoing individuals disclaim any beneficial ownership of these warrants. The business address
    of HCM is 277 Park Avenue, 23rd Floor, New York, NY 10172 and the business address of the Highbridge Funds is c/o HedgeServ (Cayman)
    Ltd., Cricket Square, Floor 6, George Town, Grand Cayman KY1-1104, Cayman Islands.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<!-- Field: Page; Sequence: 19; Value: 2 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 30px"><font style="font-size: 10pt">(5)</font></td>
<td><font style="font-size: 10pt">Includes (i) 787,490 warrants held by ALSV Limited; (ii) 177,487 warrants held by Windermere Ireland
    Fund PLC; (iii) 966,811 warrants held by APSV, LLC; (iv) 646,555 warrants held by ASIG International Limited; and (v) 134,615 warrants
    held by DS Liquid Div RVA ARST, LLC. Aristeia may be deemed the beneficial owner of the securities described herein in its capacity
    as the investment manager of the Aristeia Funds, which are the holders of such securities. As investment manager of each Aristeia
    Fund, Aristeia has voting and investment control with respect to the securities held by each Aristeia Fund. Anthony M. Frascella
    and William R. Techar are the Co-Chief Investment Officers of Aristeia. Each of Aristeia and such individuals disclaim beneficial
    ownership of the securities referenced herein except to the extent of its or his direct or indirect economic interest in the Aristeia
    Funds. The business address of such holders is One Greenwich Plaza, Third Floor, Greenwich, Connecticut 06830.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 30px"><font style="font-size: 10pt">(6)</font></td>
<td><font style="font-size: 10pt">WF Fund is the record holder of such warrants. WAM is the investment manager to WF Fund and has
    voting and investment power over these securities. The sole member and manager of WAM is Wolverine Holdings. Robert R. Bellick and
    Christopher L. Gust may be deemed to control WTP, the general partner of Wolverine Holdings. Each of Robert R. Bellick, Christopher
    L. Gust, Wolverine Holdings, WTP, and WAM disclaims beneficial ownership of the securities held by the WF Fund. The business address
    of such holders is 175 W. Jackson Blvd., Suite 340, Chicago, Illinois 60604.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 30px"><font style="font-size: 10pt">(7)</font></td>
<td><font style="font-size: 10pt">The business address of Cantor Fitzgerald &amp; Co. is 110 East 59th Street, New York, NY 10022.
    Howard W. Lutnick, through indirect beneficial ownership of the general partners of Cantor Fitzgerald &amp; Co., has voting and investment
    control over the warrants. Mr. Lutnick disclaims beneficial ownership of the shares except to the extent of any pecuniary interest
    therein.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Each of the Selling Securityholders that is a
broker-dealer or an affiliate of a broker-dealer has represented to us that it purchased the securities offered by this prospectus in
the ordinary course of business and, at the time of purchase of those securities, did not have any agreements, understandings or other
plans, directly or indirectly, with any person to distribute those shares.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Material Relationships with the Selling Securityholders</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">For a description of our relationships with the
Selling Securityholders and their affiliates see the section entitled &#8220;<i>Certain Relationships and Related Transactions</i>&#8221;
in our Amended Annual Report, incorporated by reference herein</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Other Material Relationships</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">David Kirsch, the Chairman of our Board, has
no pecuniary interest in shares of our Common Stock or warrants and disclaims any beneficial ownership of the shares of our Common Stock
or warrants beneficially owned by Mudrick Capital Management, L.P. and its affiliates.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Michael Harrison, a member of our board of directors,
has an indirect pecuniary interest in shares of our Common Stock beneficially owned by Sprott Private Resource Streaming and Royalty
(Collector), LP. and Sprott Private Resource Lending II (Collector), LP as chief executive officer of Sprott Resource Streaming and Royalty
Corp. and/or through his fiduciary role as a Managing Partner of Sprott Private Resource Streaming and Royalty (Collector), LP. and Managing
Director of Sprott, Inc. Mr. Harrison disclaims any beneficial ownership of the shares of our Common Stock beneficially owned by Sprott
Private Resource Streaming and Royalty (Collector), LP. and Sprott Private Resource Lending II (Collector), LP.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<!-- Field: Page; Sequence: 20; Value: 2 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="text-transform: uppercase"><b>&#160;</b></font></p>
<!-- Field: Split-Segment; Name: 2 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="text-transform: uppercase"><b>&#160;</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase"><b><a name="a_005"></a>PLAN
OF DISTRIBUTION</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase"><b>&#160;</b></font></p>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are registering the issuance by us of up to
47,442,361 shares of our Common Stock that may be issued upon exercise of the warrants to purchase Common Stock, including the public
warrants, private placement warrants, forward purchase warrants, PIPE warrants, October 2020 warrants, Seller warrants and subsequently
acquired public warrants held by a Selling Securityholder and registered for resale hereunder. We are also registering the resale by the
Selling Securityholders or their permitted transferees of up to 69,814,676 shares of Common Stock and up to 19,161,491 warrants to purchase
Common Stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Selling Securityholders may offer and sell,
from time to time, their respective shares of Common Stock and warrants covered by this prospectus. The Selling Securityholders will act
independently of us in making decisions with respect to the timing, manner and size of each sale. Such sales may be made on one or more
exchanges or in the over-the-counter market or otherwise, at prices and under terms then prevailing or at prices related to the then current
market price or in negotiated transactions. The Selling Securityholders may sell their securities by one or more of, or a combination
of, the following methods:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td><font style="font-size: 10pt">on NASDAQ, in the over-the-counter market or on any other national securities exchange on which our securities are listed or traded;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td><font style="font-size: 10pt">in privately negotiated transactions;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td><font style="font-size: 10pt">in underwritten transactions;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td><font style="font-size: 10pt">in a block trade in which a broker-dealer will attempt to sell the offered securities as agent but may purchase and resell a portion of the block as principal to facilitate the transaction;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td><font style="font-size: 10pt">through purchases by a broker-dealer as principal and resale by the broker-dealer for its account pursuant to this prospectus;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td><font style="font-size: 10pt">in ordinary brokerage transactions and transactions in which the broker solicits purchasers;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td><font style="font-size: 10pt">through the writing of options (including put or call options), whether the options are listed on an options exchange or otherwise;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td><font style="font-size: 10pt">through the distribution of the securities by any Selling Securityholder to its partners, members or stockholders;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td><font style="font-size: 10pt">in short sales entered into after the effective date of the registration statement of which this prospectus forms a part;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td><font style="font-size: 10pt">by pledge to secured debts and other obligations;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td><font style="font-size: 10pt">to or through underwriters or agents;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td><font style="font-size: 10pt">&#8220;at the market&#8221; or through market makers or into an existing market for the securities; and</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
<td><font style="font-size: 10pt">any other method permitted pursuant to applicable law.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Selling Securityholders may sell the securities
at prices then prevailing, related to the then prevailing market price or at negotiated prices. The offering price of the securities from
time to time will be determined by the Selling Securityholders and, at the time of the determination, may be higher or lower than the
market price of our securities on NASDAQ or any other exchange or market. The Selling Securityholders may also sell our securities short
and deliver the securities to close out their short positions or loan or pledge the securities to broker-dealers or other financial institutions
that in turn may sell the securities. The shares may be sold directly or through broker-dealers or other financial institutions acting
as principal or agent or pursuant to a distribution by one or more underwriters on a firm commitment or best-efforts basis. The Selling
Securityholders may also enter into hedging transactions with broker-dealers or other financial institutions. In connection with such
transactions, broker-dealers or other financial institutions may engage in short sales of our securities in the course of hedging the
positions they assume with the Selling Securityholders. The Selling Securityholders may also enter into options or other transactions
with broker-dealers or other financial institutions, which require the delivery to such broker-dealer or other financial institution of
securities offered by this prospectus, which securities such broker-dealer or other financial institution may resell pursuant to this
prospectus (as supplemented or amended to reflect such transaction). In connection with an underwritten offering, underwriters or agents
may receive compensation in the form of discounts, concessions or commissions from the Selling Securityholders or from purchasers of the
offered securities for whom they may act as agents. In addition, underwriters may sell the securities to or through dealers, and those
dealers may receive compensation in the form of discounts, concessions or commissions from the underwriters and/or commissions from the
purchasers for whom they may act as agents. The Selling Securityholders and any underwriters, dealers or agents participating in a distribution
of the securities may be deemed to be &#8220;underwriters&#8221; within the meaning of the Securities Act, and any profit on the sale
of the securities by the Selling Securityholders and any commissions received by broker-dealers may be deemed to be underwriting commissions
under the Securities Act.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<!-- Field: Page; Sequence: 21; Options: NewSection; Value: 12 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</font></p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Selling Securityholders are party to the Amended
and Restated Registration Rights Agreement have agreed, and the other Selling Securityholders may agree, to indemnify an underwriter,
broker-dealer or agent against certain liabilities related to the sale of the securities, including liabilities under the Securities Act.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In order to comply with the securities laws of
certain states, if applicable, the securities must be sold in such jurisdictions only through registered or licensed brokers or dealers.
In addition, in certain states the securities may not be sold unless they have been registered or qualified for sale in the applicable
state or an exemption from the registration or qualification requirement is available and is complied with.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Selling Securityholders are subject to the
applicable provisions of the Exchange Act, including Regulation M. This regulation, if applicable to sales hereunder, may limit the timing
of purchases and sales of any of the securities offered in this prospectus by the Selling Securityholders. The anti-manipulation rules
under the Exchange Act may apply to sales of the securities in the market and to the activities of the Selling Securityholders and their
affiliates. Furthermore, Regulation M may restrict the ability of any person engaged in the distribution of the securities to engage in
market-making activities for the particular securities being distributed for a period of up to five business days before the distribution.
The restrictions may affect the marketability of the securities and the ability of any person or entity to engage in market-making activities
for the securities.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">At the time a particular offer of securities is
made, if required, a prospectus supplement will be distributed that will set forth the number of securities being offered and the terms
of the offering, including the name of any underwriter, dealer or agent, the purchase price paid by any underwriter, any discount, commission
and other item constituting compensation, any discount, commission or concession allowed or reallowed or paid to any dealer, and the proposed
selling price to the public.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">To the extent required, this prospectus may be
amended and/or supplemented from time to time to describe a specific plan of distribution. Instead of selling the securities under this
prospectus, the Selling Securityholders may sell the securities in compliance with the provisions of Rule 144 under the Securities Act,
if available, or pursuant to other available exemptions from the registration requirements of the Securities Act.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p>
<!-- Field: Page; Sequence: 22; Value: 12 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#160;</font></p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase"><b><a name="a_006"></a>DESCRIPTION
OF SECURITIES TO BE REGISTERED</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase"><b>&#160;</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>General</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">These summaries are not intended to be a complete
discussion of the rights of Company stockholders and are qualified in their entirety by reference to the Delaware General Corporation
Law and the various documents of the Company that are referred to in the summaries, as well as reference to the Second Amended and Restated
Certificate of Incorporation and Amended and Restated Bylaws, copies of which are included as Exhibits 3.1 and 3.2, respectively, to the
registration statement of which this prospectus forms a part.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Authorized Capital Stock</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Second Amended and Restated Certificate of
Incorporation authorizes the issuance of up to 400,000,000 shares of Common Stock and 10,000,000 shares of preferred stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Common Stock</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Voting Power</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Except as otherwise required by law or as otherwise
provided in any certificate of designation for any series of preferred stock, under the Second Amended and Restated Certificate of Incorporation,
the holders of our Common Stock possess all voting power for the election of directors and all other matters requiring stockholder action
and are entitled to one vote per share on matters to be voted on by stockholders. The holders of Common Stock will at all times vote together
as one class on all matters submitted to a vote of the Company&#8217;s common stockholders under the Second Amended and Restated Certificate
of Incorporation.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Preferred Shares</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Second Amended and Restated Certificate of
Incorporation provides that shares of preferred stock may be issued from time to time in one or more series. The Board is authorized to
fix the voting rights, if any, designations, powers, preferences and relative, participating, optional, special and other rights, if any,
and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. The Board is able, without stockholder
approval, to issue preferred stock with voting and other rights that could adversely affect the voting power and other rights of the holders
of the Common Stock and could have anti-takeover effects. The ability of the Board to issue preferred stock without stockholder approval
could have the effect of delaying, deferring or preventing a change of control or the removal of existing management. The Company has
no preferred stock outstanding at the date hereof. Although the Company does not currently intend to issue any shares of preferred stock,
it cannot assure you that it will not do so in the future.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Dividends</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Subject to the rights, if any, of holders of any
outstanding shares of preferred stock, the Second Amended and Restated Certificate of Incorporation provides that holders of Common Stock
are entitled to receive such dividends and other distributions, if any, as may be declared from time to time by the Board in its discretion
out of legally available funds and shall share equally on a per share basis in such dividends and distributions.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Number and Election of Directors</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Second Amended and Restated Certificate of
Incorporation and the Company&#8217;s Amended and Restated Bylaws provide that the Board will be elected at each annual meeting of stockholders.
The term of all directors shall be for one year and will expire at the next annual meeting of stockholders or until their respective successors
are duly elected and qualified. The directors were elected to the board at the annual meeting of stockholders held on May 24, 2021.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p>
<!-- Field: Page; Sequence: 23; Value: 12 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&#160;</font></p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Under the Second Amended and Restated Certificate
of Incorporation, there is no cumulative voting with respect to the election of directors, with the result that directors will be elected
by a plurality of the votes cast at a meeting of stockholders by the holders of Common Stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Liquidation Preference</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Second Amended and Restated Certificate of
Incorporation provides that in the event of voluntary or involuntary liquidation, dissolution, or winding up of the Company, the holders
of the Common Stock will be entitled to receive all of the remaining assets of the Company available for distribution to stockholders,
ratably in proportion to the number of shares of Common Stock held by them, after the rights of creditors and the holders of the preferred
stock have been satisfied.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Business Combinations</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Second Amended and Restated Certificate of
Incorporation provides that the Company will not be governed by Section&#160;203 of the DGCL and includes a provision that is substantially
similar to Section&#160;203 of the DGCL, but excludes the investment funds affiliated with sponsor and their respective successors and
affiliates and the investment funds affiliated with or managed by Mudrick Capital, Whitebox, Highbridge, Aristeia and Wolverine and their
respective successors and affiliates from the definition of &#8220;interested stockholder.&#8221;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Pre-emption Rights</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The holders of the Common Stock will not have
preemptive or other subscription rights and there will be no sinking fund or redemption provisions applicable to the Common Stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Removal of Directors; Vacancies on the Board
of Directors</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Second Amended and Restated Certificate of
Incorporation and the Company&#8217;s Amended and Restated Bylaws provide that, subject to the rights of the holders of any series of
the Company preferred stock, directors may be removed only by the affirmative vote of the holders of a majority of the voting power of
all shares then entitled to vote at an election of directors. Furthermore, subject to the rights of the holders of any series of the Company
preferred stock, any vacancy on the Company&#8217;s Board, however occurring, including a vacancy resulting from an increase in the size
of the Board, may only be filled by the affirmative vote of a majority of the Company&#8217;s directors then in office, even if less than
a quorum, or by a sole remaining director, and shall not be filled by a vote of the stockholders.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Corporate Opportunity</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Second Amended and Restated Certificate of
Incorporation provides that, to the extent allowed by applicable law, the doctrine of corporate opportunity, or any other analogous doctrine,
does not apply with respect to the Company or any of its officers or directors in circumstances where the application of such corporate
opportunity doctrine would conflict with any fiduciary duties or contractual obligations they may have. Mudrick Capital, Whitebox, Highbridge,
Aristeia and Wolverine and the investment funds affiliated with them, including their respective partners, principals, directors, officers,
members, managers, equity holders and/or employees (including any of the foregoing who serve as officers or directors of the Company)
do not have any fiduciary duty to refrain from engaging directly or indirectly in the same or similar business activities or lines of
business as the Company or any of its subsidiaries, except as may otherwise be provided in separate agreement between such person or entity
and the Company.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Exclusive Forum Provision</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Second Amended and Restated Certificate of
Incorporation provides that the Court of Chancery of the State of Delaware is the exclusive forum for stockholder litigation, other than
any stockholder action to enforce any liability or duty under the Securities Act or the Exchange Act for which there is exclusive federal
or concurrent federal and state jurisdiction.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>
<!-- Field: Page; Sequence: 24; Value: 12 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&#160;</font></p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Amendment of Certificate of Incorporation
or Bylaws</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As required by the DGCL, any amendment of the
Second Amended and Restated Certificate of Incorporation must first be approved by a majority of the directors then in office and, if
required by law or the Second Amended and Restated Certificate of Incorporation, thereafter be approved by a majority of the outstanding
shares entitled to vote on the amendment, and a majority of the outstanding shares of each class entitled to vote on the amendment as
a class.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company&#8217;s Amended and Restated Bylaws
may be amended, altered or repealed by the affirmative vote of a majority of the Company directors then in office, and may also be amended,
altered or repealed by the affirmative vote of a majority of the outstanding shares entitled to vote generally in the election of directors.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Preferred Shares</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Second Amended and Restated Certificate of
Incorporation provides that shares of preferred stock may be issued from time to time in one or more series. The Board is authorized to
fix the voting rights, if any, designations, powers, preferences and relative, participating, optional, special and other rights, if any,
and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. The Board is able, without stockholder
approval, to issue preferred stock with voting and other rights that could adversely affect the voting power and other rights of the holders
of the Common Stock and could have anti-takeover effects. The ability of the Board to issue preferred stock without stockholder approval
could have the effect of delaying, deferring or preventing a change of control or the removal of existing management. The Company has
no preferred stock outstanding at the date hereof.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Warrants</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Public Warrants</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Each public warrant of the Company issued in the
IPO consummated on February&#160;12, 2018 entitles the registered holder to purchase one share of Common Stock at an exercise price of
$11.50 per share, subject to adjustment as discussed below, at any time commencing 30 days after the completion of the Recapitalization
Transaction. Pursuant to the Warrant Agreement, a public warrant holder may exercise its public warrants only for a whole number of shares
of Common Stock. The public warrants will expire five years after the completion of the Recapitalization Transaction, at 5:00 p.m., New
York City time, or earlier upon redemption or liquidation.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company is not obligated to deliver any shares
of its Common Stock pursuant to the exercise of a public warrant and will have no obligation to settle such public warrant exercise unless
a registration statement under the Securities Act with respect to the shares of Common Stock underlying the warrants is then effective
and a prospectus relating thereto is current, subject to the Company satisfying its obligations described below with respect to registration.
No public warrant will be exercisable, and the Company will not be obligated to issue any shares to holders seeking to exercise their
public warrants, unless the shares of Common Stock issuable upon such warrant exercise have been registered, qualified or deemed to be
exempt under the securities laws of the state of residence of the registered holder of the public warrants. In the event that the conditions
in the two immediately preceding sentences are not satisfied with respect to an public warrant, the holder of such public warrant will
not be entitled to exercise such public warrant and such public warrant may have no value and expire worthless. In no event will the Company
be required to net cash settle any public warrant.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to its obligations under the Amended
and Restated Registration Rights Agreement, the Company is filing the registration statement of which this prospectus forms a part for
the registration, under the Securities Act, of the shares of Common Stock issuable upon exercise of the public warrants. The Company will
use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement and a current
prospectus relating thereto, until the expiration of the public warrants in accordance with the provisions of the Warrant Agreement.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Once the public warrants become exercisable, the
Company may call the public warrants for redemption:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
<td><font style="font-size: 10pt">in whole and not in part;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<!-- Field: Page; Sequence: 25; Value: 12 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&#160;</font></p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
<td><font style="font-size: 10pt">at a price of $0.01 per public warrant;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
<td><font style="font-size: 10pt">upon not less than 30 days&#8217; prior written notice of redemption to each public warrant holder; and</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
<td><font style="font-size: 10pt">if, and only if, the last reported sale price of the Common Stock equals or exceeds $18.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 trading day period ending three business days prior to the date the Company sends the notice of redemption to the public warrant holders.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If and when the public warrants become redeemable,
the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all
applicable state securities laws.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the foregoing conditions are satisfied and
the Company issues a notice of redemption of the public warrants, each public warrant holder will be entitled to exercise his, her or
its public warrant prior to the scheduled redemption date. However, the price of the Common Stock may fall below the $18.00 redemption
trigger price (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) as well as the $11.50
per share warrant exercise price after the redemption notice is issued.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the Company calls the public warrants for redemption
as described above, the Company&#8217;s management will have the option to require any holder that wishes to exercise his, her or its
public warrant to do so on a &#8220;cashless basis.&#8221; In determining whether to require all holders to exercise their public warrants
on a &#8220;cashless basis,&#8221; the Company&#8217;s management will consider, among other factors, the Company&#8217;s cash position,
the number of public warrants that are outstanding and the dilutive effect on stockholders of issuing the maximum number of shares of
Common Stock issuable upon the exercise of its public warrants. If the Board takes advantage of this option, all holders of public warrants
would pay the exercise price by surrendering their public warrants for that number of shares of Common Stock equal to the quotient obtained
by dividing (x)&#160;the product of the number of shares of Common Stock underlying the public warrants, multiplied by the difference
between the exercise price of the public warrants and the &#8220;fair market value&#8221; (defined below) by (y)&#160;the fair market
value. The &#8220;fair market value&#8221; shall mean the average reported closing price of the Common Stock for the ten trading days
ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of public warrants. If the
Company&#8217;s management takes advantage of this option, the notice of redemption will contain the information necessary to calculate
the number of shares of Common Stock to be received upon exercise of the public warrants, including the &#8220;fair market value&#8221;
in such case. Requiring a cashless exercise in this manner will reduce the number of shares to be issued and thereby lessen the dilutive
effect of a public warrant redemption. If the Company&#8217;s management does not take advantage of this option, sponsor and its permitted
transferees would still be entitled to exercise their private placement warrants described in &#8220; <i>&#8211; Private Placement Warrants</i>&#8221;
below for cash or on a cashless basis using the same formula described above that other public warrant holders would have been required
to use had all public warrant holders been required to exercise their public warrants on a cashless basis, as described in more detail
below.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A holder of a public warrant may notify the Company
in writing in the event it elects to be subject to a requirement that such holder will not have the right to exercise such public warrant,
to the extent that after giving effect to such exercise, such person (together with such person&#8217;s affiliates), to the public warrant
agent&#8217;s actual knowledge, would beneficially own in excess of 4.9% or 9.8% (or such other amount as specified by the holder) of
the shares of Common Stock outstanding immediately after giving effect to such exercise.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the number of outstanding shares of Common
Stock is increased by a stock dividend payable in shares of Common Stock, or by a stock split-up of Common Stock or other similar event,
then, on the effective date of such stock dividend, split-up or similar event, the number of shares of Common Stock issuable on exercise
of each public warrant will be increased in proportion to such increase in outstanding Common Stock. A rights offering to holders of shares
of Common Stock entitling holders to purchase shares of Common Stock at a price less than the fair market value will be deemed a stock
dividend of a number of shares of Common Stock equal to the product of (i)&#160;the number of shares of Common Stock actually sold in
such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable
for Common Stock) and (ii)&#160;the quotient of (x)&#160;the price per share of Common Stock paid in such rights offering and (y)&#160;the
fair market value. For these purposes, (i)&#160;if the rights offering is for securities convertible into or exercisable for Common Stock,
in determining the price payable for the Common Stock, there will be taken into account any consideration received for such rights, as
well as any additional amount payable upon exercise or conversion and (ii)&#160;fair market value means the volume weighted average price
of the Common Stock as reported during the ten trading day period ending on the trading day prior to the first date on which the Common
Stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p>
<!-- Field: Page; Sequence: 26; Value: 12 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&#160;</font></p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition, if the Company, at any time while
the public warrants are outstanding and unexpired, pays a dividend or makes a distribution in cash, securities or other assets to the
holders of shares of Common Stock on account of such Common Stock (or other shares of our share capital into which the warrants are convertible),
other than (i)&#160;as described above, or (ii)&#160;certain ordinary cash dividends, then the warrant exercise price will be decreased,
effective immediately after the effective date of such event, by the amount of cash and/or the fair market value of any securities or
other assets paid on each share of Common Stock in respect of such event.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the number of outstanding shares of Common
Stock is decreased by a consolidation, combination, reverse share split or reclassification of shares of Common Stock or other similar
event, then, on the effective date of such consolidation, combination, reverse share split, reclassification or similar event, the number
of Common Stock issuable on exercise of each public warrant will be decreased in proportion to such decrease in outstanding share of Common
Stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Whenever the number of shares of Common Stock
purchasable upon the exercise of the public warrants is adjusted, as described above, the public warrant exercise price will be adjusted
by multiplying the public warrant exercise price immediately prior to such adjustment by a fraction (x)&#160;the numerator of which will
be the number of shares of Common Stock purchasable upon the exercise of the public warrants immediately prior to such adjustment and
(y)&#160;the denominator of which will be the number of shares of Common Stock so purchasable immediately thereafter.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In case of any reclassification or reorganization
of the outstanding shares of Common Stock (other than those described above or that solely affects the par value of such Common Stock),
or in the case of any merger or consolidation of the Company with or into another corporation (other than a consolidation or merger in
which the Company is the continuing corporation and that does not result in any reclassification or reorganization of the outstanding
shares of Common Stock), or in the case of any sale or conveyance to another corporation or entity of the Company&#8217;s assets or other
property as an entirety or substantially as an entirety in connection with which the Company is dissolved, the holders of the public warrants
will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the public warrants
and in lieu of the shares of Common Stock immediately theretofore purchasable and receivable upon the exercise of the rights represented
thereby, the kind and amount of shares or other securities or property (including cash) receivable upon such reclassification, reorganization,
merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the public warrants would have
received if such holder had exercised his, her or its warrants immediately prior to such event. If less than 70% of the consideration
receivable by the holders of shares of Common Stock in such transaction is payable in the form of shares of common stock in the successor
entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be
so listed for trading or quoted immediately following such event, and if the registered holder of the public warrant properly exercises
the public warrant within 30 days following public disclosure of such transaction, the public warrant exercise price will be reduced as
specified in the Warrant Agreement based on the Black-Scholes value (as defined in the Warrant Agreement) of the public warrant. The purpose
of such exercise price reduction is to provide additional value to holders of the public warrants when an extraordinary transaction occurs
during the exercise period of the public warrants pursuant to which the holders of the public warrants otherwise do not receive the full
potential value of the public warrants.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The public warrants have been issued in registered
form under the Warrant Agreement between Continental Stock Transfer&#160;&amp; Trust Company, as warrant agent, and the Company. The Warrant
Agreement provides that the terms of the public warrants may be amended without the consent of any holder to cure any ambiguity or correct
any defective provision, but requires the approval by the holders of at least 65% of the then issued and outstanding public warrants to
make any change that adversely affects the interests of the registered holders of public warrants, including any modification or amendment
to increase the exercise price or shorten the exercise period.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p>
<!-- Field: Page; Sequence: 27; Value: 12 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&#160;</font></p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The public warrants may be exercised upon surrender
of the public warrant certificate on or prior to the expiration date at the offices of the warrant agent, with the exercise form on the
reverse side of the public warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price
(or on a cashless basis, if applicable), by certified or official bank check payable to the Company, for the number of public warrants
being exercised. The public warrant holders do not have the rights or privileges of holders of shares of Common Stock and any voting rights
until they exercise their public warrants and receive shares of Common Stock. After the issuance of shares of Common Stock upon exercise
of the public warrants, each holder will be entitled to one vote for each share held of record on all matters to be voted on by stockholders.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">No fractional shares will be issued upon exercise
of the public warrants. If, upon exercise of the public warrants, a holder would be entitled to receive a fractional interest in a share,
the Company will, upon exercise, round down to the nearest whole number the number of shares of Common Stock to be issued to the public
warrant holder.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The foregoing description of the public warrants
do not purport to be complete and are subject to and qualified in their entirety by reference to the Warrant Agreement, a copy of which
is included as Exhibit&#160;4.2 to the registration statement of which this prospectus forms a part.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Private Placement Warrants</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The (a)&#160;6,700,000 warrants to purchase one
share of Common Stock issued to the sponsor pursuant to the Private Placement Warrant Purchase Agreement, dated as of January&#160;15,
2018, by and between the Company and the sponsor, (b)&#160;1,040,000 warrants to purchase one share of Common Stock issued to Cantor pursuant
to the Private Placement Warrant Purchase Agreement, dated as of January&#160;15, 2018, by and between the Company and Cantor, including
the shares of Common Stock issuable upon exercise of the private placement warrants, are not transferable, assignable or salable until
30 days after the completion of the Recapitalization Transaction (except, among other limited exceptions, to the Company&#8217;s officers
and directors and other persons or entities affiliated with the sponsor or Cantor) and they will not be redeemable so long as they are
held by the sponsor, Cantor or their permitted transferees. The sponsor, Cantor or their permitted transferees, have the option to exercise
the private placement warrants on a cashless basis. Except as described below, the private placement warrants have terms and provisions
that are identical to those of the public warrants described above. If the private placement warrants are held by holders other than the
sponsor, Cantor or their permitted transferees, the private placement warrants will be redeemable by the Company and exercisable by the
holders on the same basis as the public warrants. For as long as the private placement warrants are held by Cantor or its designees or
affiliates, they may not be exercised after February&#160;7, 2023, which is five years from the effective date of the registration statement
filed in connection with the IPO.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If holders of the private placement warrants elect
to exercise them on a cashless basis, they would pay the exercise price by surrendering their warrants for that number of shares of Common
Stock equal to the quotient obtained by dividing (x)&#160;the product of the number of shares of Common Stock underlying the warrants,
multiplied by the difference between the exercise price of the private placement warrants and the &#8220;fair market value&#8221; (defined
below) by (y)&#160;the fair market value. The &#8220;fair market value&#8221; shall mean the average reported closing price of the Common
Stock for the ten trading days ending on the third trading day prior to the date on which the notice of private placement warrant exercise
is sent to the warrant agent.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The foregoing description of the private placement
warrants does not purport to be complete and are subject to and qualified in their entirety by reference to the Warrant Agreement, a copy
of which is included as Exhibit&#160;4.2 to the registration statement of which this prospectus forms a part.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Forward Purchase Warrants</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On May&#160;29, 2020, in connection with the closing
of the Recapitalization Transaction, the Company issued 2,500,000 warrants to purchase one share of Common Stock at a price of $11.50
per share issued to sponsor pursuant to the Forward Purchase Contract. The forward purchase warrants have substantially the same terms
as the private placement warrants.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p>
<!-- Field: Page; Sequence: 28; Value: 12 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&#160;</font></p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The foregoing description of the forward purchase
warrants does not purport to be complete and are subject to and qualified in their entirety by reference to the Warrant Agreement, a copy
of which is included as Exhibit&#160;4.2 to the registration statement of which this prospectus forms a part.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>PIPE Warrants Issued in Private Investment</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On May&#160;29, 2020, in connection with the closing
of the Recapitalization Transaction, the Company issued 7,596,309 shares of Common Stock pursuant to the Subscription Agreements and issued
3,249,999 PIPE warrants to the Initial Subscribers in the private investment. The PIPE warrants have substantially the same terms as the
public warrants.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The foregoing description of the PIPE warrants
does not purport to be complete and are subject to and qualified in their entirety by reference to the Warrant Agreement, a copy of which
is included as Exhibit&#160;4.3 to the registration statement of which this prospectus forms a part.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>October 2020 warrants</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The October 2020 warrants have been issued in
registered form under the October 2020 Warrant Agreement between Continental Stock Transfer &amp; Trust Company, as warrant agent, and
the Company and shall initially be represented only by one or more global warrants deposited with the warrant agent, as custodian on behalf
of The Depository Trust Company, or DTC, and registered in the name of Cede &amp; Co., a nominee of DTC, or as otherwise directed by DTC.
The October 2020 Warrant Agreement provides that the terms of the October 2020 warrants may be amended without the consent of any holder
to cure any ambiguity or correct any defective provision, but any change that adversely affects the interests of the registered holders
of the October 2020 warrants, including any modification or amendment to increase the October 2020 warrant price or shorten the exercise
period, requires the approval of the registered holder of the October 2020 warrant.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The initial exercise price is $10.50 per share
of Common Stock. The exercise price is subject to appropriate adjustment in the event of certain stock dividends and distributions, stock
splits, stock combinations, reclassifications or similar events affecting our Common Stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The October 2020 warrants are exercisable at any
time after the date of issuance, and at any time up to the earlier to occur of (x) the date that is five years from the date of issuance
and (y) the date fixed by the Company for redemption if the Company elects to redeem the October 2020 warrants (as described below), at
which time any unexercised October 2020 warrants will expire and cease to be exercisable. The October 2020 warrants may be exercised upon
surrender of the warrant certificate on or prior to the expiration date at the offices of the warrant agent, with the exercise form on
the reverse side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price (or
on a cashless basis, if applicable), by certified or official bank check payable to the Company, for the number of October 2020 warrants
being exercised. The October 2020 warrant holders do not have the rights or privileges of holders of shares of Common Stock and any voting
rights until they exercise their October 2020 Warrants and receive shares of Common Stock. After the issuance of shares of Common Stock
upon exercise of the October 2020 warrants, each holder will be entitled to one vote for each share of Common Stock held of record on
all matters to be voted on by stockholders.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">No fractional shares will be issued upon exercise
of the October 2020 warrants. If, upon exercise of the October 2020 warrants, a holder would be entitled to receive a fractional interest
in a share, the Company will, upon exercise, round down to the nearest whole number the number of shares of Common Stock to be issued
to the October 2020 warrant holder.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Once the October 2020 warrants become exercisable,
the Company may call the October 2020 warrants for redemption:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
<td><font style="font-size: 10pt">in whole and not in part;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
<td><font style="font-size: 10pt">at a price of $0.01 per October 2020 warrant;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<!-- Field: Page; Sequence: 29; Value: 12 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&#160;</font></p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
<td><font style="font-size: 10pt">upon not less than 30 days&#8217; prior written notice of redemption to each October 2020 warrant holder; and</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 48px">&#160;</td>
<td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
<td><font style="font-size: 10pt">if, and only if, the last reported sale price of the Common Stock equals or exceeds $17.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 trading day period ending three business days prior to the date the Company sends the notice of redemption to the October 2020 warrant holders.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If and when the October 2020 warrants become redeemable,
the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all
applicable state securities laws.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the foregoing conditions are satisfied and
the Company issues a notice of redemption of the October 2020 warrants, each October 2020 warrant holder will be entitled to exercise
his, her or its October 2020 warrant prior to the scheduled redemption date. However, the price of the Common Stock may fall below the
$17.00 redemption trigger price (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like)
as well as the $10.50 per share warrant exercise price after the redemption notice is issued.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the Company calls the October 2020 warrants
for redemption as described above, the Company&#8217;s management will have the option to require any holder that wishes to exercise his,
her or its October 2020 warrant to do so on a &#8220;cashless basis.&#8221; In determining whether to require all holders to exercise
their October 2020 warrants on a &#8220;cashless basis,&#8221; the Company&#8217;s management will consider, among other factors, the
Company&#8217;s cash position, the number of October 2020 warrants that are outstanding and the dilutive effect on stockholders of issuing
the maximum number of shares of Common Stock issuable upon the exercise of its October 2020 warrants. If the Company&#8217;s Board takes
advantage of this option, all holders of October 2020 warrants would pay the exercise price by surrendering their October 2020 warrants
for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common
Stock underlying the October 2020 warrants, multiplied by the difference between the exercise price of the Warrants and the &#8220;fair
market value&#8221; (defined below) by (y) the fair market value. The &#8220;fair market value&#8221; shall mean the average reported
closing price of the Common Stock for the ten trading days ending on the third trading day prior to the date on which the notice of redemption
is sent to the holders of warrants. If the Company&#8217;s management takes advantage of this option, the notice of redemption will contain
the information necessary to calculate the number of shares of Common Stock to be received upon exercise of the October 2020 warrants,
including the &#8220;fair market value&#8221; in such case. Requiring a cashless exercise in this manner will reduce the number of shares
to be issued and thereby lessen the dilutive effect of an October 2020 warrant redemption.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A holder of an October 2020 warrant may notify
the Company in writing in the event it elects to be subject to a requirement that such holder will not have the right to exercise such
October 2020 warrant, to the extent that after giving effect to such exercise, such person (together with such person&#8217;s affiliates),
to the October 2020 warrant agent&#8217;s actual knowledge, would beneficially own in excess of 4.9% or 9.8% (or such other amount as
specified by the holder) of the shares of Common Stock outstanding immediately after giving effect to such exercise.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">This summary of certain provisions of the October
2020 warrants is not complete, and is qualified in its entirety by, the provisions of the October 2020 Warrant Agreement. For the complete
terms of the October 2020 warrants and the October 2020 Warrant Agreement, you should refer to the October 2020 Warrant Agreement, and
the form of October 2020 warrant included as Exhibit A to the October 2020 Warrant Agreement, filed as Exhibit 4.4 to the registration
statement of which this prospectus forms a part.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Assumed Warrants of Seller</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Stockholders of Seller&#8217;s predecessor received
warrants pursuant to the Seller Warrant Agreement with a 7-year term that represented 17.5% of the outstanding common stock of Seller,
which we refer to as the Seller warrants. Pursuant to the Purchase Agreement, the liabilities and obligations under the Seller Warrant
Agreement were assumed by the Company upon consummation of the transactions contemplated under the Purchase Agreement. Seller and the
Company elected to treat the Recapitalization Transaction as if it constituted a Fundamental Change under the Seller Warrant Agreement
and each Seller warrant outstanding and unexercised immediately prior to the effective time is now exercisable to purchase shares of Common
Stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p>
<!-- Field: Page; Sequence: 30; Value: 12 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&#160;</font></p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The initial number of shares of Seller&#8217;s
common stock issuable upon exercise of the Seller warrants was determined by the Bankruptcy Court pursuant to Seller&#8217;s predecessor&#8217;s
plan of reorganization. Pursuant to the Seller Warrant Agreement, the number of shares of Seller&#8217;s common stock for which a Seller
warrant is exercisable, and the exercise price per share, are subject to adjustment from time to time upon the occurrence of certain events,
including (i) any issuance of a dividend on Seller&#8217;s common stock, payable in cash or additional shares of Seller&#8217;s common
stock, (ii) any subdivision, split, reclassification or recapitalization of outstanding Seller&#8217;s common stock into a greater number
of shares, or (iii) any combination, reclassification or recapitalization of outstanding Seller&#8217;s common stock into a smaller number
of shares. As set forth in the Seller Warrant Agreement, the exercise price of the Seller warrants on any exercise date will be equal
to the product of (x) the amount obtained by dividing (A) Seller&#8217;s adjusted equity value, as defined in the Seller Warrant Agreement,
as of such exercise date by (B) the total share number, as defined in the Seller Warrant Agreement, as of such date multiplied by (y)
the cheap stock factor, as defined in the Seller Warrant Agreement, as of such date. Additionally, in the case of any reclassification
or capital reorganization of Seller&#8217;s capital stock, the holder of each Seller warrant outstanding immediately prior to the occurrence
of such reclassification or reorganization shall have the right to receive upon exercise of the applicable Seller warrant, the kind and
amount of stock, other securities, cash or other property that such holder would have received if such Seller warrant had been exercised.
As of June 15, 2021, there were 12,721,623 Seller warrants outstanding that were exercisable to purchase an aggregate of 3,569,129 shares
of our Common Stock. As of January 19, 2021, the exercise price of each Seller warrant was equal to $40.31 per share and each Seller warrant
is exercisable into approximately 0.28055 shares of Common Stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Under certain circumstances, such as a liquidity
event, as defined in the Seller Warrant Agreement, the Seller warrants may be exercised on a cashless basis to the extent that, as of
the exercise date, the fair market value, as defined in the Seller Warrant Agreement, of a share of Common Stock exceeds the exercise
price, which cashless exercise would reduce the number of shares of Common Stock issuable. In the event of a liquidity event in which
the fair market value, as defined in the Seller Warrant Agreement, of a share of Common Stock, as of the exercise date, exceeds the exercise
price, no cashless exercise would be available. If any exercise of a Seller warrant would result in a fraction of a share of Common Stock,
in lieu of issuing such fractional share, the Company may elect to make a cash payment in respect of such fractional share, in an amount
equal to the product of such fraction multiplied by the fair market value, as defined in the Seller Warrant Agreement, of a share of Common
Stock, as of the exercise date.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition, if the Company issues (or, as provided
in the Seller Warrant Agreement, is deemed to issue), after the effective date of the Seller warrants, any additional shares, as defined
in the Seller Warrant Agreement, of Common Stock, without consideration or for consideration per share less than the fair market value
of Common Stock immediately prior to such issuance or, if such additional shares are issued (or deemed to be issued) to any restricted
person, as defined in the Seller Warrant Agreement, then the cheap stock factor, as defined in the Seller Warrant Agreement, shall be
reduced, thereby increasing the number of shares of Common Stock for which a Seller warrant is exercisable and reducing the per share
exercise price of the Seller warrants.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the Seller Warrant Agreement, no Seller
warrants may be transferred if such transfer would result in any violation of the Securities Act or any state securities laws or regulations,
or any other applicable federal or state laws or order, unless the Company is then already subject to the reporting obligations under
Sections 13 or 15(d)&#160;of the Exchange Act.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the Seller Warrant Agreement, holders
of Seller warrants are not entitled to any of the rights of a stockholder or a holder of any other securities of the Company. Holders
of Seller warrants have no right to vote or to receive dividends or to consent or to receive notice as a stockholder in respect of any
meeting of stockholders for the election of directors of the Company or of any other matter, or any rights whatsoever as stockholders
of the Company (including appraisal rights, dissenters rights, subscription rights or otherwise), or be deemed the holder of capital stock
of the Company.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the Seller Warrant Agreement, if the
Company issues or sells equity securities to any person who was a stockholder of Seller&#8217;s predecessor on the effective date of the
Seller warrants for consideration per share that is greater than the then exercise price of the Seller warrants, then each registered
holder (or in the case of Seller warrants evidenced by global warrant certificates, each beneficial holder) that is an accredited investor
would have the right for a period of 20 days after the Company delivers notice of such issuance or sale to such eligible holder, to participate
in such issuance or sale on a pro rata basis (based on such eligible holder&#8217;s percentage ownership of shares of Common Stock) and
all other outstanding options, warrants, or convertible securities that also have a pro rata right to participate in such issuance or
sale.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p>
<!-- Field: Page; Sequence: 31; Value: 12 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&#160;</font></p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Following the Recapitalization Transaction, eligible
holders are not entitled to participate in any of the following exempted issuances: (i)&#160;issuances of equity securities in connection
with the refinancing or repayment of any indebtedness or debt securities of the Company or any of its subsidiaries, (ii)&#160;issuances
of equity securities to employees, directors, consultants and other service providers pursuant to an equity compensation plan approved
by the Board, (iii)&#160;issuances of equity securities by means of a pro rata distribution to all holders of Common Stock, (iv)&#160;issuances
of equity securities in a public offering, and (v)&#160;issuances of equity securities upon exercise, conversion or exchange of any equity
securities that were issued in any issuance described in any of the foregoing exempted issuances. Pursuant to the Seller Warrant Agreement,
if the Common Stock is listed for trading on a national securities exchange, the Company must use commercially reasonable efforts to list
the Seller warrants for trading on such national securities exchange (subject to applicable listing requirements). In addition, if any
holder of shares of Common Stock is granted piggy-back registration rights, the holders of Common Stock issued upon exercise of the Seller
warrants would also be granted piggyback registration rights on substantially the same terms as such other holder.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the Seller Warrant Agreement, in the
event of a merger of the Company into, or a consolidation of the Company with, or a sale of all or substantially all of the Company&#8217;s
assets to, any other person, or any merger of another person into the Company, in each case, in which the previously outstanding shares
of Common Stock are cancelled, reclassified or converted or changed into or exchanged for securities of the Company and/or other property
(including cash), and such transaction is not a liquidity event, as defined in the Seller Warrant Agreement, the holder of each Seller
warrant would have the right upon any subsequent exercise (and payment of the applicable exercise price) to receive (out of legally available
funds) the kind and amount of stock, other securities, cash and assets that such holder would have received if such Seller warrant had
been exercised immediately prior to such transaction.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the Seller Warrant Agreement, if the
Company shall be a party to or otherwise engage in any transaction or series of related transactions constituting (x)&#160;a merger of
the Company into, a consolidation of the Company with, or a sale of all or substantially all of the Company&#8217;s assets to, any other
person, or (y)&#160;any merger of another person into the Company in which, in the case of clause (x)&#160;or clause (y), the previously
outstanding shares of Common Stock shall be cancelled, reclassified or converted or changed into or exchanged for securities of the Company
or other property (including cash) or any combination of the foregoing; and (ii)&#160;such transaction or series of related transactions
is not a liquidity event (as defined in the Seller Warrant Agreement) (any such transaction or series of related transactions, is referred
to as a &#8220;Fundamental Change&#8221; under the Seller Warrant Agreement), the holder of each Seller warrant outstanding immediately
prior to the occurrence of such Fundamental Change will have the right upon any subsequent exercise (and payment of the applicable exercise
price) to receive the kind and amount of stock, other securities, cash and assets that such holder of a Seller warrant would have received
if such Seller warrant had been exercised pursuant to the terms provided in the Seller Warrant Agreement immediately prior to such Fundamental
Change (assuming such holder of a Seller warrant failed to exercise his, her or its rights of election, if any, as to the kind or amount
of stock, securities, cash or other property receivable upon such Fundamental Change); provided, however, that the amount of such stock,
other securities, cash and assets that would be received upon exercise of a Seller warrant following the consummation of such Fundamental
Change shall be calculated on the applicable exercise date in a manner consistent with, and on terms as nearly as equivalent as practicable
to, the provisions of the Seller Warrant Agreement regarding (i)&#160;the number of securities into which the Seller warrant shall be
exercisable and (ii)&#160;the exercise price for the purchase of such securities under the Seller warrant, with respect to the aggregate
consideration received by the Company stockholders in such Fundamental Change. The Seller Warrant Agreement further provides that upon
each Fundamental Change, appropriate adjustment shall be deemed to be made, including, without limitation, with respect to the kind and
amount of stock, securities, cash or assets thereafter acquirable upon exercise of each Seller warrant, such that the provisions of the
Seller Warrant Agreement shall thereafter be applicable, as nearly as possible, to any shares of stock, securities, cash or assets thereafter
acquirable upon exercise of each Seller warrant. If the Company is not the surviving or resulting person from such Fundamental Change,
the Company may not consummate a Fundamental Change transaction unless the surviving or resulting person assumes, by written instrument
substantially similar in form and substance to this Agreement, the obligation to deliver to the holders of Seller warrants such shares
of stock, securities, cash or assets which such holder would be entitled to receive upon exercise of each Seller warrant.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p>
<!-- Field: Page; Sequence: 32; Value: 12 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&#160;</font></p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The foregoing description of the Seller warrants
does not purport to be complete and are subject to and qualified in their entirety by reference to the Seller Warrant Agreement, a copy
of which is included as Exhibit&#160;4.1 to the registration statement of which this prospectus forms a part.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase"><b><a name="a_007"></a>INTEREST
OF NAMED EXPERTS AND COUNSEL</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase"><b>&#160;</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The restated consolidated financial statements
of Hycroft Mining Holding Corporation as of December&#160;31, 2020 and 2019 and for each of the years in the two-year period ended December
31, 2020 have been incorporated by reference herein and in this Registration Statement in reliance upon the report of Plante &amp; Moran,
PLLC, an independent registered public accounting firm, incorporated by reference herein, and upon the authority of said firm as experts
in accounting and auditing.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Employees of M3 Engineering&#160;&amp; Technology
Corporation and SRK Consulting (U.S.), Inc. and Steven Newman (RM-SME) and Richard F. DeLong (P.Geo) have prepared the Hycroft Technical
Report. Each of the individuals who prepared the Hycroft Technical Report is a qualified person as defined in subpart 1300 of Regulation
S-K. Steven Newman, the Director of Feasibility Studies at the Company at the time of the issuance of the Hycroft Technical Report. Richard
F. DeLong is an employee of EM Strategies, Inc. Other than Steven Newman, who was employed by the Company, none of the qualified persons,
or the employers of any of the qualified persons, is an affiliate of the Company.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><a name="a_008"></a>INCORPORATION BY REFERENCE</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase"><b>&#160;</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The SEC permits us to &#8220;incorporate by reference&#8221;
the information and reports we file with it. This means that we can disclose important information to you by referring to another document.
The information that we incorporate by reference is considered to be part of this prospectus, and later information that we file with
the SEC automatically updates and supersedes this information. We incorporate by reference the documents listed below, except to the extent
information in those documents is different from the information contained in this prospectus, and all future documents filed with the
SEC under Sections 13(a), 13(c), 14, or 15(d) of the Exchange Act (other than the portions thereof deemed to be furnished to the SEC pursuant
to Item 9 or Item 12) until we terminate the offering of these securities:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-indent: -27pt">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 36px; font-size: 10pt"><font style="font-size: 10pt">1.</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Our amended and restated </font><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1718405/000171840521000029/hymc-20201231.htm"><font style="font-size: 10pt">Annual Report on Form 10-K/A for the year ended December 31, 2020, filed on May 14, 2021</font></a> <font style="font-size: 10pt">(the &#8220;Amended Annual Report&#8221;), including those portions of our </font><a href="http://www.sec.gov/Archives/edgar/data/1718405/000110465921049914/tm2112056-2_def14a.htm"><font style="font-size: 10pt">Proxy Statement on Schedule 14A filed on April 14, 2021</font></a> <font style="font-size: 10pt">that are incorporated by reference in such Amended Annual Report;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 36px; font-size: 10pt"><font style="font-size: 10pt">2.</font></td>
<td style="font-size: 10pt"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1718405/000171840521000046/hymc-20210331.htm"><font style="font-size: 10pt">Our Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 filed on May 17, 2021</font></a><font style="font-size: 10pt">; and</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 36px; font-size: 10pt"><font style="font-size: 10pt">3.</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">Our Current Reports on Form 8-K, which were filed on </font><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1718405/000171840521000006/hymc-20210111.htm"><font style="font-size: 10pt">January 12, 2021</font></a><font style="font-size: 10pt">, </font><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1718405/000110465921005529/tm213608d1_8k.htm"><font style="font-size: 10pt">January 20, 2021</font></a><font style="font-size: 10pt">, </font><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1718405/000110465921035679/tm219587d1_8k.htm"><font style="font-size: 10pt">March 12, 2021</font></a><font style="font-size: 10pt">, </font><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1718405/000171840521000031/hymc-20210324.htm"><font style="font-size: 10pt">March 24, 2021</font></a><font style="font-size: 10pt">, </font><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1718405/000171840521000036/hymc-20210415.htm"><font style="font-size: 10pt">April 15, 2021</font></a><font style="font-size: 10pt">, </font><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1718405/000171840521000039/hymc-20210421.htm"><font style="font-size: 10pt">April 22, 2021</font></a><font style="font-size: 10pt">, </font><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1718405/000171840521000041/hymc-20210504.htm"><font style="font-size: 10pt">May 6, 2021</font></a><font style="font-size: 10pt">, </font><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1718405/000171840521000048/hymc-20210517.htm"><font style="font-size: 10pt">May 17, 2021</font></a> <font style="font-size: 10pt">and </font><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1718405/000171840521000054/hymc-20210524.htm"><font style="font-size: 10pt">May 24, 2021</font></a> <font style="font-size: 10pt">(in each case excluding any information furnished pursuant to Item 2.02 or Item 7.01 of any such Current Report on Form 8-K unless otherwise indicated therein);</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 36px; font-size: 10pt"><font style="font-size: 10pt">4.</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">The description of our common stock in the Second Amended and Restated Certificate of Incorporation of Mudrick Capital Acquisition Corporation and Amended and Restated Bylaws of Mudrick Capital Acquisition Corporation, each of which is incorporated by reference to Exhibit 3.1 and Exhibit 3.2, respectively, to our </font><a href="http://www.sec.gov/Archives/edgar/data/1718405/000110465920069879/tm2021571d1_8k12b.htm"><font style="font-size: 10pt">Current Report on Form 8-K12B, filed with the SEC on June 4, 2020</font></a><font style="font-size: 10pt">; and</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 24px">&#160;</td>
<td style="width: 36px; font-size: 10pt"><font style="font-size: 10pt">5.</font></td>
<td style="font-size: 10pt"><font style="font-size: 10pt">All documents we file with the SEC under Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act (other than those made pursuant to Item 2.02 or Item 7.01 of Form 8-K or other information &#8220;furnished&#8221; to the SEC unless we specifically state in such Current Report that such information is to be considered &#8220;filed&#8221; under the Exchange Act or we incorporate it by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act) after the date of this prospectus and prior to the termination of this offering made by way of this prospectus. These documents include periodic reports, such as Proxy Statements, Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K (other than the portions of those documents not deemed to be filed, which is deemed not to be incorporated by reference in this Registration Statement).</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<!-- Field: Page; Sequence: 33; Value: 12 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&#160;</font></p></div>
<div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-indent: -27pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">To the extent that any statement in this prospectus
is inconsistent with any statement that is incorporated by reference and that was made on or before the date of this prospectus, the statement
in this prospectus shall supersede such incorporated statement. The incorporated statement shall not be deemed, except as modified or
superseded, to constitute a part of this prospectus or the registration statement. Any statement contained in a document incorporated
or deemed to be incorporated herein by reference shall be deemed to be modified or superseded for purposes of this</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in">Registration Statement to the extent that a statement
contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies
or supersedes such statement. Statements contained in this prospectus as to the contents of any contract or other document are not necessarily
complete and, in each instance, we refer you to the copy of each contract or document filed as an exhibit to our various filings made
with the SEC.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We will provide to each person, including any
beneficial owner, to whom a prospectus is delivered, upon written or oral request, a copy of any or all of the reports or documents that
have been incorporated by reference in this prospectus but not delivered with the prospectus. You may access a copy of any or all of these
filings, free of charge, at <i>www.sec.gov</i>, or by writing us at the following address or telephoning us at the number below:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in">Hycroft Mining Holding Corporation<br/>
Attn: Investor Relations<br/>
8181 E. Tufts Ave., Suite 510<br/>
Denver, Colorado 80237<br/>
(303) 253-3267</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">You may also direct your requests via e-mail to
investors@hycroftmining.com.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><a name="a_009"></a>LEGAL MATTERS</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase"><b>&#160;</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Neal, Gerber &amp; Eisenberg LLP will pass upon
the validity of the Common Stock and warrants covered by this prospectus. Any underwriters or agents will be advised about other issues
relating to the offering by counsel to be named in any applicable prospectus supplement.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<!-- Field: Page; Sequence: 34 -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&#160;</font></p></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><b>&#160;</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><b>&#160;</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><b><img alt="" src="https://www.sec.gov/Archives/edgar/data/0001718405/000110465921091694/image_001.jpg" style="height: 119px; width: 247px"/></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><font style="font-size: 12pt"><b>HYCROFT
MINING HOLDING CORPORATION</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><font style="font-size: 12pt">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><font style="font-size: 12pt"><b>69,814,676
shares of Common Stock</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><font style="font-size: 12pt"><b>19,161,491
Warrants</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><font style="font-size: 12pt"><b>47,442,361
shares of Common Stock Issuable upon Exercise of Warrants</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>
<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="font-size: 1pt; border-top: Black 0.5pt solid">&#160;</div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><b>&#160;</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><font style="font-size: 12pt"><b>PROSPECTUS</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>
<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="font-size: 1pt; border-top: Black 0.5pt solid">&#160;</div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><b>&#160;</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><font style="font-size: 12pt"><b>July
13, 2021</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>
<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="font-size: 1pt; border-top: Black 0.5pt solid">&#160;</div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>You should rely only on the
information contained or incorporated by reference in this prospectus. We have not authorized anyone to provide you with different information.
You should not assume that the information contained or incorporated by reference in this prospectus is accurate as of any date other
than the date of this prospectus. We are not making an offer of these securities in any state where the offer is not permitted.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<!-- Field: Page; Sequence: 35; Options: Last -->
<div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
</text>
</description></filename></sequence></type></document>
</body></html>